Trans septal implantable medical device

Information

  • Patent Grant
  • 10391319
  • Patent Number
    10,391,319
  • Date Filed
    Thursday, August 17, 2017
    6 years ago
  • Date Issued
    Tuesday, August 27, 2019
    4 years ago
Abstract
An implantable medical device (IMD) includes a housing that is configured to be positioned at least in part in a chamber of a heart, and in some cases, in a right ventricle (RV) proximate an RV facing side of the ventricular septum of the heart. When so provided, an RV electrode may be fixed relative to the housing to be proximate the RV facing side of the ventricular septum. An LV electrode may be spaced a distance from the RV electrode and the housing such that the LV electrode is positioned at least partially within the ventricular septum. An LV electrode position adjustment assembly may be used to adjust the depth at which the LV electrode is positioned within the ventricular septum.
Description
TECHNICAL FIELD

The disclosure relates generally to implantable medical devices, and relates more particularly to implantable medical devices that may extend at least partially through a septum within a patient's heart.


BACKGROUND

Implantable medical devices are commonly used today to monitor a patient and/or deliver therapy to a patient. For example, implantable sensors are often used to monitor one or more physiological parameters of a patient, such as heart beats, heart sounds, ECG, respiration, etc. In another example, pacing devices are often used to treat patients suffering from various heart conditions that may result in a reduced ability of the heart to deliver sufficient amounts of blood to a patient's body. Such heart conditions may lead to slow, rapid, irregular, and/or inefficient heart contractions. To help alleviate some of these conditions, various medical devices (e.g., pacemakers, defibrillators, etc.) can be implanted in a patient's body. Such devices may monitor and in some cases provide electrical stimulation to the heart to help the heart operate in a more normal, efficient and/or safe manner. Under some circumstances, it can be beneficial to sense and/or pace two or more chambers of the heart.


SUMMARY

This disclosure relates generally to implantable medical devices, and relates more particularly to implantable medical devices that extend at least partially through a septum within a patient's heart. In some cases, the implantable medical devices may be configured to be disposed adjacent a septum within a patient's heart. In some cases, the implantable medical devices may be configured to extend at least partially into the septum, and in some cases, entirely through the septum. The septum may be the ventricular septum that divides the left and right ventricles. When so provided, the implantable medical device may be configured to sense and/or pace both ventricles of the heart. In some cases, the implantable medical device may be delivered to the ventricle septum via the more accessible right ventricle of the heart. In some cases, the septum may be the atrial septum the divides the left and right atriums. In some cases, the septum may be the atrial/ventricular septum that extends between the right atrium and the left ventricle. These are just examples.


In one example of the disclosure, an implantable medical device (IMD) is configured for deployment at a ventricular septum of a patient's heart, the ventricular septum of the patient's heart having a right ventricle (RV) facing side and a left ventricle (LV) facing side. The IMD may include a housing that includes a proximal end and a distal end. The IMD is configured to be positioned at least in part in the right ventricle (RV) of the patient's heart with the distal end of the housing proximate the RV facing side of the ventricular septum once the IMD is implanted in the patient's heart. The IMD may include a power source that is disposed within the housing, as well as circuitry that is also disposed within the housing and that is operably coupled to the power source. A first RV electrode may be disposed adjacent the distal end of the housing and may be positioned to be facing the RV facing side of the ventricular septum once the IMD is implanted. The first RV electrode may be operatively coupled with the circuitry in the housing. A second RV electrode may be spaced proximally of the first RV electrode and may be operatively coupled with the circuitry in the housing. An LV electrode may be positioned distally of the first RV electrode and at least partially in the ventricular septum once the IMD is implanted. The LV electrode may be operatively coupled with the circuitry in the housing. The IMD may include an LV electrode position adjustment assembly for adjusting a distance that the LV electrode may be positioned distally of the first RV electrode. The LV electrode position adjustment assembly may include a coupling that is secured relative to the housing and that is configured to mate with a separate adjustment tool that can move the coupling relative to the housing to adjust the distance that the LV electrode is positioned distally of the first RV electrode.


Alternatively or additionally to any of the embodiments above, the LV electrode position adjustment assembly may include a fixation helix extending distally from the housing with the LV electrode positioned on the fixation helix. The fixation helix may include a proximal shaft portion extending through a lumen of the housing and terminating in the coupling such that rotating the coupling rotates the fixation helix relative to the housing and causes the fixation helix to thread itself into the ventricular septum.


Alternatively or additionally to any of the embodiments above, the LV electrode position adjustment assembly may include an inner shaft operatively coupled to the coupling and an outer shaft threadedly engaged with the inner shaft and configured to not rotate relative to the housing, wherein rotation of the inner shaft via the coupling results in translation of the outer shaft relative to the housing. The LV electrode may be secured relative to the outer shaft and may translate with the outer shaft.


Alternatively or additionally to any of the embodiments above, at least a portion of the outer shaft has a cross-sectional profile that engages a complementary engagement portion of the housing to prevent rotation of the outer shaft relative to the housing.


Alternatively or additionally to any of the embodiments above, the cross-sectional profile may include a non-circular cross-sectional profile and the complementary engagement portion of the housing may include a distal opening in a lumen that receives at least part of the outer shaft.


Alternatively or additionally to any of the embodiments above, the coupling may include a rotatable tether loop coupled to a proximal end of the inner shaft, such that rotating the rotatable tether loop rotates the inner shaft relative to the outer shaft, thereby causing the outer shaft to translate in response.


Alternatively or additionally to any of the embodiments above, the IMD may further include a spring contact disposed within the housing and operably coupled with the circuitry, the spring contact making sliding electrical contact with a portion of the outer shaft that is electrically coupled with the LV electrode.


Alternatively or additionally to any of the embodiments above, the IMD may further include one or more fixation tines that are configured to extend into the ventricular septum and curve over to anchor the IMD in place relative to the ventricular septum.


Alternatively or additionally to any of the embodiments above, the power source may include a battery.


Alternatively or additionally to any of the embodiments above, the IMD may be a dual chamber leadless cardiac pacemaker (LCP).


In another example of the disclosure, an implantable medical device (IMD) may be configured for deployment within a heart chamber of a patient's heart, near a septum of the patient's heart. The septum of the patient's heart may have a first chamber facing side facing the heart chamber and a second opposing chamber facing side. The IMD may include a housing that is configured to be positioned at least in part in the heart chamber proximate the first chamber facing side of the septum once the IMD is implanted in the patient's heart. The IMD may also include a power source disposed within the housing. Circuitry may be disposed within the housing and may be operatively coupled to the power source. One or more first chamber electrodes that are operatively coupled with the circuitry in the housing may be fixed relative to the housing and may be positioned to be proximate the first chamber facing side of the heart chamber once the IMD is implanted. The housing may define a lumen, and the IMD may include an outer shaft that extends through the lumen and is translatable relative to the lumen. A second chamber electrode may be disposed at or near a distal end of the outer shaft and may be operably coupled with the circuitry disposed within the housing. An inner shaft may be threadedly engaged with the outer shaft such that the inner shaft may be rotated relative to the outer shaft in order to effect translation of the outer shaft relative to the housing. The outer shaft may be translatable between a retracted position in which the second chamber electrode is proximate the first chamber facing side of the septum and an extended position in which the second chamber electrode extends at least partially into the septum.


Alternatively or additionally to any of the embodiments above, at least a portion of the outer shaft may have a cross-sectional profile that engages a complementary engagement portion of the housing to prevent rotation of the outer shaft relative to the housing.


Alternatively or additionally to any of the embodiments above, the inner shaft may extend proximally through the lumen and may terminate in a coupling such that rotating the coupling rotates the inner shaft relative to the outer shaft.


Alternatively or additionally to any of the embodiments above, the IMD may further include one or more fixation tines that are configured to extend into the septum and curve over to anchor the IMD in place relative to the septum.


Alternatively or additionally to any of the embodiments above, the IMD may further include a spring contact disposed within the housing and operably coupled with the circuitry, the spring contact making sliding electrical contact with a portion of the outer shaft that is electrically coupled with the second chamber electrode.


Alternatively or additionally to any of the embodiments above, the LV electrode may serve as an antenna for communication purposes.


Alternatively or additionally to any of the embodiments above, the IMD may be a dual chamber leadless cardiac pacemaker (LCP) and the LCP may sense electrical activity on one side of the ventricular septum and deliver an actionable response on the other side of the ventricular septum.


In another example of the disclosure, a method of facilitating dual chamber pacing of a heart may include advancing an implantable medical device (IMD) to a position proximate a first side of a septum of the heart, the IMD including a housing and two first chamber electrodes disposed relative to the housing, the IMD further including a second chamber electrode and an electrode position adjustment assembly with a coupling for adjusting a position of the second chamber electrode relative to the housing. An adjustment tool may be mated to the coupling of the electrode position adjustment assembly and the adjustment tool may be manipulated to move the coupling relative to the housing to adjust the position of the second chamber electrode relative to the housing. A fixation mechanism may be deployed to secure the IMD relative to the septum.


Alternatively or additionally to any of the embodiments above, the method may further include testing for capture of the heart prior to deploying the fixation mechanism, moving the IMD to a different position proximate the first side of the septum if capture is not achieved, and testing for capture again.


Alternatively or additionally to any of the embodiments above, the method may further include testing for capture with the second chamber electrode positioned at a first distance relative to the housing, manipulating the adjustment tool to move the coupling relative to the housing to adjust the distance that the second chamber electrode is positioned a second distance relative to the housing, and testing for capture again.


The above summary is not intended to describe each and every disclosed embodiment or every implementation of the present disclosure. The Figures and Description which follow more particularly exemplify these and other illustrative embodiments.





BRIEF DESCRIPTION OF THE FIGURES

The disclosure may be more completely understood in consideration of the following description in connection with the accompanying drawings, in which:



FIG. 1 is a schematic illustration of a human heart;



FIG. 2 is a schematic block diagram of an implantable medical device (IMD) in accordance with the disclosure;



FIG. 3 is a schematic block diagram of an implantable medical device (IMD) in accordance with the disclosure;



FIG. 4 is an enlarged end view of part of the IMD of FIG. 3;



FIG. 5 is a schematic block diagram of another example adjustment mechanism;



FIG. 6 is a perspective view of an IMD that is a leadless cardiac pacemaker (LCP) in accordance with the disclosure;



FIG. 7 is a cross-sectional view of the IMD of FIG. 6;



FIG. 8 is a schematic view of a certain components of the IMD of FIG. 6;



FIG. 9 is a schematic view of an IMD in combination with a delivery device in accordance with the disclosure;



FIG. 10 is a schematic block diagram of an illustrative leadless cardiac pacemaker (LCP), which may be considered as being an example of one of the IMDs of FIGS. 2, 3 and 6;



FIG. 11 is a flow diagram showing an illustrative method of facilitating dual chamber cardiac pacing;



FIG. 12 is a flow diagram showing another illustrative method of facilitating dual chamber cardiac pacing; and



FIG. 13 is a flow diagram showing another illustrative method of facilitating dual chamber cardiac pacing.





While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.


DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.


The following description should be read with reference to the drawings in which similar structures in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.



FIG. 1 is a schematic illustration of a human heart H. The heart H includes a right side and a left side, relative to the person's perspective. The right side of the heart H includes an RA (right atrium) and an RV (right ventricle). The left side of the heart H includes an LA (left atrium) and an LV (left ventricle). A ventricular septum 10 separates the RV and the LV and an atrial septum 11 separates RA and the LA. The heart H may also be considered as including an atrioventricular septum 17 between the RA and the LV. The ventricular septum 10 may be considered as having an RV facing side 12 and an LV facing side 14. The atrial septum 11 may be considered as including a RA facing side 13 and a RA facing side 15.


It is known that portions of the heart wall, including the ventricular septum 10, have conduction pathways that are involved in causing contractions in the RV and the LV. In some cases, reaching the RV through the vasculature, such as through the superior vena cava or the inferior vena cava and through the right atrium (not illustrated), may be easier than reaching the LV in an intravascular approach. In some cases, debris may be formed within the heart H as a result of placing and manipulating implantable devices within the heart H. In some cases, debris within the RV may be less problematic for the patient than debris within the LV, as debris within the RV may pass into the patient's lungs which can act as a filter while potential debris within the LV may pass directly into the patient's brain, potentially causing a stroke or other complications. Moreover, in some cases, the presence of a significant foreign object (e.g. an implantable medical device) within the heart H may cause tissue ingrowth and/or clotting to occur as a result of the body's natural response to the presence of the foreign body. Such clots, if released, are less of a concern in the RV than the LV.


In some instances, an Implantable Medical Device (IMD) may be configured to be deployed within the RV, next to or proximate the RV facing side 12 of the ventricular septum 10. In some cases, as will be discussed, an IMD may additionally or alternatively be deployed within the RA, next to or proximate the RA facing side 13 of the atrial septum 11. In some cases, a portion of the IMD may, for example, extend partially into the ventricular septum 10, or even completely through the ventricular septum 10, in order to place one or more electrodes in position to capture the aforementioned conduction pathways through the ventricular septum 10 that control the contraction of the LV, or to otherwise sense or pace within the LV. It will be appreciated that in some cases, the portion or portions of the IMD that penetrate into the LV may be minimized in size in order to minimize the body's natural response to such a foreign body. In some cases, the portion or portions of the IMD that penetrate into the LV, and in some instances even the portion or portions of the IMD that remain within the RV, may be coated with or otherwise include one or more anticoagulant materials or materials that encourage endothelialization of the surfaces exposed to blood flow in the chamber.



FIG. 2 is a highly schematic diagram of an illustrative IMD 20 that may, for example, be utilized proximate the RV facing side 12 of the ventricular septum 10. In some cases, it is envisioned that the IMD 20 may be utilized proximate the RA facing side 13 of the atrial septum 11. In some cases, the septum may be the atrial/ventricular septum 17 that is between the right atrium RA and the left ventricle LV.


In some cases, the IMD 20 may include a housing 22 that may be considered as including a proximal end 21 and a distal end 23. The housing 22 may, for example, be configured to be disposed at least partially within the RV, with the distal end 23 of the housing 22 being next to or proximate the RV facing side 12 of the ventricular septum 10, for example.


A power source 24 may be disposed within the housing 22. In some cases, the power source 24 may be a battery. In some instances, the power source 24 may be a rechargeable power source, such as a rechargeable battery, a capacitor such as a super-capacitor and/or any other suitable rechargeable power source or source capable of harvesting power transmitted wirelessly from another device. In some cases, for example, energy may be transmitted to the power source 24 via RF power transfer. Circuitry 26 may be disposed within the housing 22 and may be operatively coupled to the power source 24 such that the power source 24 can power operation of the circuitry 26. In some cases, if the power source 24 is rechargeable, the circuitry 26 may also regulate recharging operations of the power source 24. In some cases, the circuitry 26 may include or be coupled to an antenna, inductive loop and/or other energy receiving element for wirelessly receiving energy to recharge the battery. In some cases, energy may be harvested from bodily movement.


In some cases, as illustrated, the IMD 20 may include a first RV electrode 28 that is adjacent the distal end 23 of the housing 22. It will be appreciated that the first RV electrode 28 is positioned relative to the housing 22 such that the first RV electrode 28 will be facing the RV facing side 12 of the ventricular septum 10 once the IMD 20 has been implanted. The first RV electrode 28 is operably coupled with the circuitry 26 via a conductor 30. A second RV electrode 32 may be spaced proximally of the first RV electrode 28 and may be operatively coupled with the circuitry 26 via a conductor 34.


In some cases, the IMD 20 may include an LV electrode 36 that, as can be seen, may be positioned distally of the first RV electrode 28. In some cases, the LV electrode 36 may be positioned such that the LV electrode 36 penetrates at least partially into the ventricular septum 10 once the IMD 20 is implanted. In some cases, the LV electrode 36 may extend only partially into the ventricular septum 10. In some instances, the LV electrode 36 may extend all the way through the ventricular septum 10 and may in fact be positioned at the LV facing side 14 of the ventricular septum 10. The LV electrode 36 may be operatively coupled with the circuitry 26 via a conductor 38. In some cases, the IMD 20 may include an LV electrode position adjustment assembly 40 that is schematically shown in FIG. 2. The LV electrode position adjustment assembly 40 may, as will be shown with respect to subsequent Figures, be adjustable in length in order to adjust the position of the LV electrode 36 relative to the housing 22 and thus adjust the relative depth to which the LV electrode 36 penetrates within the ventricular septum 10. In some cases, the LV electrode 36 may function as an antenna for communication purposes.


In some cases, the LV electrode position adjustment assembly 40 may include a threaded mechanism that when rotated causes the LV electrode 36 to move outward to penetrate further into the ventricular septum 10. In some cases, the LV electrode position adjustment assembly 40 may include a push rod that when pushed by a pusher device (e.g. delivery mandrel or catheter) causes the LV electrode 36 to move outward to penetrate further into the ventricular septum 10. In some cases, a latching mechanism may be provided to hold the position of the LV electrode 36 in place. In some cases, the LV electrode position adjustment assembly 40 may telescope and thus may assume a shorter profile in the retracted position. In some cases, the LV electrode position adjustment assembly 40 may include a hydraulic mechanism that when activated moves the LV electrode 36 outward to penetrate further into the ventricular septum 10. In some cases, the LV electrode position adjustment assembly 40 may include an electric motor configured to drive the LV electrode 36 outward to penetrate further into the ventricular septum 10. In some cases, the LV electrode position adjustment assembly 40 may include a solenoid to drive the LV electrode 36 outward to penetrate further into the ventricular septum 10. These are just some examples implantations of the LV electrode position adjustment assembly 40. In some cases, the LV electrode position adjustment assembly 40 may be configured to also retract the LV electrode 36 relative to the ventricular septum 10 and toward the housing 22. When so provided, the positioning of the LV electrode 36 in the ventricular septum 10 may be adjustable in both proximal and distal directions. In some cases, for example, the IMD 20 may sense electrical activity in one portion of the heart H and deliver an actionable response, such as but not limited to pacing, to another portion of the heart H. For example, the IMD 20 may sense electrical activity on the RV facing side 12 of the ventricular septum 10, such as via the RV electrode 28, and may pace on the LV facing side 14 of the ventricular septum 10 using the LV electrode 36.



FIG. 3 is a highly schematic illustration of an IMD 50 that may be configured for deployment within a heart chamber of a patient's heart, near a septum of the heart. The septum may be considered as having a first chamber facing side that faces the heart chamber and a second opposing chamber facing side. In some cases, the heart chamber may be the RV, and thus the septum in question is the ventricular septum 10, having an RV facing side 12 and an LV facing side 14. This is merely illustrative, as for example the IMD 50 may be implantable within the RA, meaning that the septum in question is the atrial septum 11, having an RA facing side 13 and an LA facing side 15. The IMD 50 includes a housing 52 having a proximal end 51 and a distal end 53.


The IMD 50 may include one or more first chamber electrodes 54 that are fixed relative to the housing 52 and that are positioned to be proximate the first chamber facing side of the heart chamber once the IMD is implanted. As illustrated, the IMD 50 includes a first chamber electrode 54a and a second chamber electrode 54b. The first chamber electrode 54a may be operatively coupled with the circuitry 26 via a conductor 56a. The second chamber electrode 54b may be operatively coupled with the circuitry 26 via a conductor 56b.


In some cases, a lumen 58 may extend through the housing 52 from the proximal end 51 to the distal end 53. As can be seen, an adjustment mechanism 60 may extend through the lumen 58. In some cases, the adjustment mechanism 60 may be considered as being an example of the LV electrode position adjustment assembly 40 referenced in FIG. 2. A second chamber electrode 62 may be seen disposed at or near a distal end 63 of the adjustment mechanism 60 and may be operatively coupled with the circuitry 26 via a conductor 64 (shown partially in phantom). In some cases, the adjustment mechanism 60 may include an outer shaft 66 that extends through the lumen 58, and as will be discussed may be translatable relative to the lumen 58 and housing 52. The adjustment mechanism 60 may include an inner shaft 68 that is threadedly engaged with the outer shaft 66 such that the inner shaft 68 may be rotated relative to the outer shaft 66 in order to effect translation of the outer shaft 66 relative to the housing 52. In some cases, the outer shaft 66 may be translatable between a retracted position in which the second chamber electrode 62 is proximate the first chamber facing side of the septum and an extended position in which the second chamber electrode 62 extends at least partially into the septum. In some cases, a plurality of second chamber electrodes 62 may be provided, each at a different position along the outer shaft 66 so that each is at a different depth in the septum. The circuitry 26 may include a selector (not explicitly shown) to select which one (or more) of the plurality of second chamber electrodes 62 to use.


The outer shaft 66 may be coated with a steroid or other substance to minimize inflammation. In some cases, the outer shaft 66 may have an atraumatic tip at its distal end. The atraumatic tip may be semi-flexible and may be rounded to avoid cutting the myocardium. In some cases, the outer shaft may contain fixation elements, such as flexible talons extending laterally out from the side walls of the outer shaft 66. Such fixation elements may provide additional stability and may be used in in addition to, or in place of, fixation tines 104 (see FIG. 6) and/or anchors 216 (see FIG. 10). In some cases, one or more of the fixation elements may be electrically active, for example.


In some cases, the outer shaft 66 may be constrained against rotating relative to the housing 52. By holding the outer shaft 66 from rotating relative to the housing 52, rotating the inner shaft 68 relative to the outer shaft 66 (and relative to the housing 52) may cause the outer shaft 66 to translate without rotating. In some cases, rotating the inner shaft 68 in a first direction may cause the outer shaft 66 to translate in a distal direction while rotating the inner shaft 68 in a second, opposite direction, may cause the outer shaft 66 to translate in a proximal direction. In some cases, the outer shaft 66 or at least a portion of the outer shaft 66 may have a cross-sectional profile that engages a complementary engagement portion of the housing 52 in order to prevent rotation of the outer shaft 66 relative to the housing 52 while still allowing translation of the outer shaft 66 relative to the housing 52. FIG. 4 provides an enlarged view of part of the distal end 53 of the housing 52 of FIG. 3. The outer shaft 66 is shown as having a cross-sectional profile, such as but not limited to a non-circular cross-sectional profile, which is complementary in shape to an aperture 70 that represents a distal end of the lumen 58. It will be appreciated that this is just one example of a suitable relationship between an outer profile of the outer shaft 66 relative to the aperture 70.


Returning to FIG. 3, the adjustment mechanism 60 may include a coupling 72 that may, for example, be rigidly coupled to the inner shaft 68 such that rotation of the coupling 72 produces rotation of the inner shaft 68. The coupling 72 may be configured such that a separate adjustment tool may be mated with the coupling 72. In some cases, the adjustment tool may be used to rotate the coupling 72 to rotate the inner shaft 68. In some cases, the coupling 72 may, for example, represent a tether loop. Rotating the tether loop may cause the inner shaft 68 to rotate in the same direction as the tether loop, and the rotation of the inner shaft 68 relative to the outer shaft 66 while the outer shaft 66 is constrained from rotating causes translation of the outer shaft 66 relative to the housing 52. It is contemplated that the coupling may be a mechanical coupling, an electrical coupling, a hydraulic coupling and/or any other suitable coupling as desired, depending on the type of LV electrode position adjustment assembly 40 used.


Turning to FIG. 5, and in some cases, it is contemplated that the adjustment mechanism 60 may include a fixation helix. FIG. 5 shows an outer shaft 76 that includes a shaft portion 78 and a helix portion 80. In some cases, the shaft portion 78 is threadedly engaged with the inner shaft 68. In some cases, the shaft portion 78 is rigidly coupled with the inner shaft 68 and the shaft portion 78 is not constrained against rotation. In some cases, the inner shaft 68 and the shaft portion 78 may be considered as forming a proximal shaft portion that extends proximally back to the coupling 72 (FIG. 3). As a result, and in some cases, rotation of the inner shaft 68 may cause rotation of the outer shaft 76 such that the helix portion 80 is able to twist or screw itself into the septum. In some cases, the helix portion 80 may be soldered or welded to the inner shaft 68. In some cases, the helix portion 80 may be integrally formed as part of the inner shaft 68. In some cases, the second chamber electrode 62 may be disposed at or near a distal end 83 of the helix portion 80 and may be operatively coupled to circuitry 26. In some cases, a plurality of second chamber electrodes 62 may be provided, each at a different position along the helix portion 80 so that each is at a different depth in the septum. The circuitry 26 may include a selector (not explicitly shown in FIG. 3) to select which one (or more) of the plurality of second chamber electrodes 62 to use.



FIG. 6 provides an illustration of an IMD 90 that is a leadless cardiac pacemaker (LCP). The IMD 90 includes a housing 92 that extends from a proximal end 91 to a distal end 93. A tether loop 94 is secured relative to the proximal end 91 and may, for example, be considered as being an example of the coupling 72 (FIG. 3). The tether loop 94 may, for example, be used to hold the IMD 90 relative to a delivery device during implantation, and can be engaged with an adjustment tool to rotate the tether loop 94. At the distal end 93, an outer shaft 96 bearing an LV electrode 98 extends distally from the distal end 93. A first RV electrode 100 may be disposed at or near the distal end 93 of the housing 92. In some cases, as shown, a second RV electrode 102 may be disposed at or near the proximal end 91 of the housing 92. In some cases, the second RV electrode 102 may be a ring electrode, but this is not required. The IMD 90 includes fixation tines 104 that may be configured to extend into heart muscle and then curve over on themselves (as illustrated) to anchor the IMD 90 to the heart.



FIG. 7 is a cross-sectional view of the illustrative IMD 90, taken along line 7-7 of FIG. 6. As can be seen, an inner shaft 106 is threadedly engaged with the outer shaft 96 and extends proximally to the tether loop 94 such that rotation of the tether loop 94 causes the inner shaft 106 to rotate relative to the outer shaft 96. If the outer shaft 96 is constrained against rotation relative to the housing 92 (as discussed with respect to FIG. 4, for example), rotation of the tether loop 94 relative to the housing 92 will cause the outer shaft 96 to translate either distally or proximally, depending on the threading direction of the inner shaft 106 and the outer shaft 96, and the direction in which the tether loop 94 is rotated.


It will be appreciated that there needs to be an electrical connection between the circuitry 26 (FIGS. 2, 3 and 7) and the LV electrode 98. As shown schematically in FIG. 7, a connector 110 provides an electrical connection between the circuitry 26 and the moving outer shaft 96. FIG. 8 provides greater detail regarding an illustrative but non-limiting example of the connector 110. In some cases, a spring contact 112 may be coupled with the circuitry 26. The spring contact 112 may make sliding electrical contact with a portion of the outer shaft 96 that is electrically coupled with the LV electrode 98.



FIG. 9 provides an example of implanting the IMD 90 proximate the ventricular septum 10. As illustrated, the first RV electrode 100 and the second RV electrode 102 are both ring electrodes, but this is not required. The IMD 90 is secured within a delivery device 120, which includes an implantation tool 122 that extends within the delivery device 120 and that may be used for several purposes. For example, the implantation tool 122 may engage the tether loop 94 to hold the IMD 90 relative to the delivery device 120 while delivering the IMD 90 to the implantation site. In some cases, the implantation tool 122 may subsequently be used to rotate the tether loop 94 relative to the housing of the IMD 90 and thus extend or retract the outer shaft 96 bearing the LV electrode 98. As shown, the LV electrode 98 is proximate the LV facing side 14 of the ventricular septum 10. In some cases, the LV electrode 98 may instead be disposed within the ventricular septum 10, at an intermediate depth between the RV facing side 12 of the ventricular septum 10 and the LV facing side 14 of the ventricular septum 10. In some cases, a plurality of LV electrodes may be provided, each at a different position along the outer shaft 96 so that each is at a different depth in the ventricular septum 10. The circuitry 26 may include a selector (not explicitly shown) to select which one (or more) of the plurality of LV electrodes to use.



FIG. 10 is a conceptual schematic block diagram of an illustrative IMD, and more specifically a leadless cardiac pacemaker (LCP) that may operate to sense physiological signals and parameters and deliver one or more types of electrical stimulation therapy to the heart of the patient. Example electrical stimulation therapy may include bradycardia pacing, rate responsive pacing therapy, cardiac resynchronization therapy (CRT), anti-tachycardia pacing (ATP) therapy and/or the like. As can be seen in FIG. 10, the LCP 200 may be a compact device with all components housed within the LCP 200 or directly on a housing 220. In some instances, the LCP 200 may include one or more of a communication module 202, a pulse generator module 204, an electrical sensing module 206, a mechanical sensing module 208, a processing module 210, an energy storage module 212, and electrodes 214. The LCP 200 may, for example, be considered as being an example of the IMD 20 (FIG. 2), the IMD 50 (FIG. 3) and/or the IMD 90 (FIG. 6).


As depicted in FIG. 10, the LCP 200 may include electrodes 214, which can be secured relative to the housing 220 and electrically exposed to tissue and/or blood surrounding the LCP 200. The electrodes 214 may generally conduct electrical signals to and from the LCP 200 and the surrounding tissue and/or blood. Such electrical signals can include communication signals, electrical stimulation pulses, and intrinsic cardiac electrical signals, to name a few. Intrinsic cardiac electrical signals may include electrical signals generated by the heart and may be represented by an electrocardiogram (ECG).


The electrodes 214 may include one or more biocompatible conductive materials such as various metals or alloys that are known to be safe for implantation within a human body. In some instances, the electrodes 214 may be generally disposed on either end of the LCP 200 and may be in electrical communication with one or more of the modules 202, 204, 206, 208, and 210. In embodiments where the electrodes 214 are secured directly to the housing 220, an insulative material may electrically isolate the electrodes 214 from adjacent electrodes, the housing 220, and/or other parts of the LCP 200. In some instances, some or all of the electrodes 214 may be spaced from the housing 220 and may be connected to the housing 220 and/or other components of the LCP 200 through connecting wires. In such instances, the electrodes 214 may be placed on a tail (not shown) that extends out away from the housing 220. As shown in FIG. 10, in some embodiments, the LCP 200 may include electrodes 214′. The electrodes 214′ may be in addition to the electrodes 214, or may replace one or more of the electrodes 214. The electrodes 214′ may be similar to the electrodes 214 except that the electrodes 214′ are disposed on the sides of the LCP 200. In some cases, the electrodes 214′ may increase the number of electrodes by which the LCP 200 may deliver communication signals and/or electrical stimulation pulses, and/or may sense intrinsic cardiac electrical signals, communication signals, and/or electrical stimulation pulses.


The electrodes 214 and/or 114′ may assume any of a variety of sizes and/or shapes, and may be spaced at any of a variety of spacings. For example, the electrodes 214 may have an outer diameter of two to twenty millimeters (mm). In other embodiments, the electrodes 214 and/or 114′ may have a diameter of two, three, five, seven millimeters (mm), or any other suitable diameter, dimension and/or shape. Example lengths for the electrodes 214 and/or 214′ may include, for example, one, three, five, ten millimeters (mm), or any other suitable length. As used herein, the length is a dimension of the electrodes 214 and/or 214′ that extends away from the outer surface of the housing 220. In some instances, at least some of the electrodes 214 and/or 214′ may be spaced from one another by a distance of twenty, thirty, forty, fifty millimeters (mm), or any other suitable spacing. The electrodes 214 and/or 214′ of a single device may have different sizes with respect to each other, and the spacing and/or lengths of the electrodes on the device may or may not be uniform.


In some instances, an LV electrode 214″ may also be provided. The LV electrode 214″ may be supported by an LV electrode support 256 that extends away from the housing 220. In some cases, the LV electrode support 256 is configured to place the LV electrode 214″ within the ventricular septum 10, and in electrical communication with conduction pathways extending through the ventricular septum 10 that control the contraction of the LV. In some instances, the LV electrode support 256 may extend entirely through the ventricular septum 10 in order to place an LV electrode 214″ within the LV and in contact with the LV facing side 14 of the ventricular septum 10.


In the embodiment shown, the communication module 202 may be electrically coupled to two or more of the electrodes 214, 214′ and/or 214″ and may be configured to deliver communication pulses to tissues of the patient for communicating with other devices such as sensors, programmers, other medical devices, and/or the like. Communication signals, as used herein, may be any modulated signal that conveys information to another device, either by itself or in conjunction with one or more other modulated signals. In some embodiments, communication signals may be limited to sub-threshold signals that do not result in capture of the heart yet still convey information. The communication signals may be delivered to another device that is located either external or internal to the patient's body. In some instances, the communication may take the form of distinct communication pulses separated by various amounts of time. In some of these cases, the timing between successive pulses may convey information. The communication module 202 may additionally be configured to sense for communication signals delivered by other devices, which may be located external or internal to the patient's body.


The communication module 202 may communicate to help accomplish one or more desired functions. Some example functions include delivering sensed data, using communicated data for determining occurrences of events such as arrhythmias, coordinating delivery of electrical stimulation therapy, and/or other functions. In some cases, the LCP 200 may use communication signals to communicate raw information, processed information, messages and/or commands, and/or other data. Raw information may include information such as sensed electrical signals (e.g. a sensed ECG), signals gathered from coupled sensors, and the like. In some embodiments, the processed information may include signals that have been filtered using one or more signal processing techniques. Processed information may also include parameters and/or events that are determined by the LCP 200 and/or another device, such as a determined heart rate, timing of determined heartbeats, timing of other determined events, determinations of threshold crossings, expirations of monitored time periods, accelerometer signals, activity level parameters, blood-oxygen parameters, blood pressure parameters, heart sound parameters, and the like. In some cases, processed information may, for example, be provided by a chemical sensor or an optically interfaced sensor. Messages and/or commands may include instructions or the like directing another device to take action, notifications of imminent actions of the sending device, requests for reading from the receiving device, requests for writing data to the receiving device, information messages, and/or other messages commands.


In at least some embodiments, the communication module 202 (or the LCP 200) may further include switching circuitry to selectively connect one or more of the electrodes 214, 214′ and/or 214″ to the communication module 202 in order to select which of the electrodes 214, 214′ and/or 214″ that the communication module 202 delivers communication pulses with. It is contemplated that the communication module 202 may be communicating with other devices via conducted signals, radio frequency (RF) signals, optical signals, acoustic signals, inductive coupling, and/or any other suitable communication methodology. Where the communication module 202 generates electrical communication signals, the communication module 202 may include one or more capacitor elements and/or other charge storage devices to aid in generating and delivering communication signals. In the embodiment shown, the communication module 202 may use energy stored in the energy storage module 212 to generate the communication signals. In at least some examples, the communication module 202 may include a switching circuit that is connected to the energy storage module 212 and, with the switching circuitry, may connect the energy storage module 212 to one or more of the electrodes 214/214′/214″ to generate the communication signals.


As shown in FIG. 10, a pulse generator module 204 may be electrically connected to one or more of the electrodes 214, 214′ and/or 214″. The pulse generator module 204 may be configured to generate electrical stimulation pulses and deliver the electrical stimulation pulses to tissues of a patient via one or more of the electrodes 214, 214′ and/or 214″ in order to effectuate one or more electrical stimulation therapies. Electrical stimulation pulses as used herein are meant to encompass any electrical signals that may be delivered to tissue of a patient for purposes of treatment of any type of disease or abnormality. For example, when used to treat heart disease, the pulse generator module 204 may generate electrical stimulation pacing pulses for capturing the heart of the patient, i.e. causing the heart to contract in response to the delivered electrical stimulation pulse. In some of these cases, the LCP 200 may vary the rate at which the pulse generator module 204 generates the electrical stimulation pulses, for example in rate adaptive pacing. In other embodiments, the electrical stimulation pulses may include defibrillation/cardioversion pulses for shocking the heart out of fibrillation or into a normal heart rhythm. In yet other embodiments, the electrical stimulation pulses may include anti-tachycardia pacing (ATP) pulses. It should be understood that these are just some examples. The pulse generator module 204 may include one or more capacitor elements and/or other charge storage devices to aid in generating and delivering appropriate electrical stimulation pulses. In at least some embodiments, the pulse generator module 204 may use energy stored in the energy storage module 212 to generate the electrical stimulation pulses. In some particular embodiments, the pulse generator module 204 may include a switching circuit that is connected to the energy storage module 212 and may connect the energy storage module 212 to one or more of the electrodes 214/214′/214″ to generate electrical stimulation pulses. In some cases, the pulse generator module 204 may provide pacing pulses to pace the RV of the heart H using electrode 214, and may provide pacing pulses to the LV of the heart H using electrode 214″. In some cases, the pacing pulses generated for pacing the RV of the heart H by the pulse generator module 204 may be offset in time, have a different duration, have a different amplitude and/or have a different shape from the pacing pulses generated by the pulse generator module 204 for pacing the LV of the heart H, if desired.


The LCP 200 may further include an electrical sensing module 206 and a mechanical sensing module 208. The electrical sensing module 206 may be configured to sense intrinsic cardiac electrical signals conducted from the electrodes 214, 214′ and/or 214″ to the electrical sensing module 206. For example, the electrical sensing module 206 may be electrically connected to one or more of the electrodes 214, 214′ and/or 214″ and the electrical sensing module 206 may be configured to receive cardiac electrical signals conducted through the electrodes 214, 214′ and/or 214″ via a sensor amplifier or the like. In some embodiments, the cardiac electrical signals from electrodes 214 and/or 214′ may represent local information from the RV, while the cardiac electrical signals from LV electrode 214″ may represent local information from the LV of the heart H.


The mechanical sensing module 208 may include, or be electrically connected to, various sensors, such as accelerometers, including multi-axis accelerometers such as two- or three-axis accelerometers, gyroscopes, including multi-axis gyroscopes such as two- or three-axis gyroscopes, blood pressure sensors, heart sound sensors, piezoelectric sensors, blood-oxygen sensors, and/or other sensors which measure one or more physiological parameters of the heart and/or patient. Mechanical sensing module 208, when present, may gather signals from the sensors indicative of the various physiological parameters. The electrical sensing module 206 and the mechanical sensing module 208 may both be connected to the processing module 210 and may provide signals representative of the sensed cardiac electrical signals and/or physiological signals to the processing module 210. Although described with respect to FIG. 10 as separate sensing modules, in some embodiments, the electrical sensing module 206 and the mechanical sensing module 208 may be combined into a single module. In at least some examples, the LCP 200 may only include one of the electrical sensing module 206 and the mechanical sensing module 208. In some cases, any combination of the processing module 210, the electrical sensing module 206, the mechanical sensing module 208, the communication module 202, the pulse generator module 204 and/or the energy storage module may be considered a controller of the LCP 200.


The processing module 210 may be configured to direct the operation of the LCP 200 and may, in some embodiments, be termed a controller. For example, the processing module 210 may be configured to receive cardiac electrical signals from the electrical sensing module 206 and/or physiological signals from the mechanical sensing module 208. Based on the received signals, the processing module 210 may determine, for example, occurrences and types of arrhythmias and other determinations such as whether the LCP 200 has become dislodged. The processing module 210 may further receive information from the communication module 202. In some embodiments, the processing module 210 may additionally use such received information to determine occurrences and types of arrhythmias and/or and other determinations such as whether the LCP 200 has become dislodged. In still some additional embodiments, the LCP 200 may use the received information instead of the signals received from the electrical sensing module 206 and/or the mechanical sensing module 208—for instance if the received information is deemed to be more accurate than the signals received from the electrical sensing module 206 and/or the mechanical sensing module 208 or if the electrical sensing module 206 and/or the mechanical sensing module 208 have been disabled or omitted from the LCP 200.


After determining an occurrence of an arrhythmia, the processing module 210 may control the pulse generator module 204 to generate electrical stimulation pulses in accordance with one or more electrical stimulation therapies to treat the determined arrhythmia. For example, the processing module 210 may control the pulse generator module 204 to generate pacing pulses with varying parameters and in different sequences to effectuate one or more electrical stimulation therapies. As one example, in controlling the pulse generator module 204 to deliver bradycardia pacing therapy, the processing module 210 may control the pulse generator module 204 to deliver pacing pulses designed to capture the heart of the patient at a regular interval to help prevent the heart of a patient from falling below a predetermined threshold. In some cases, the rate of pacing may be increased with an increased activity level of the patient (e.g. rate adaptive pacing). For instance, the processing module 210 may monitor one or more physiological parameters of the patient which may indicate a need for an increased heart rate (e.g. due to increased metabolic demand). The processing module 210 may then increase the rate at which the pulse generator module 204 generates electrical stimulation pulses. Adjusting the rate of delivery of the electrical stimulation pulses based on the one or more physiological parameters may extend the battery life of the LCP 200 by only requiring higher rates of delivery of electrical stimulation pulses when the physiological parameters indicate there is a need for increased cardiac output. Additionally, adjusting the rate of delivery of the electrical stimulation pulses may increase a comfort level of the patient by more closely matching the rate of delivery of electrical stimulation pulses with the cardiac output need of the patient.


For ATP therapy, the processing module 210 may control the pulse generator module 204 to deliver pacing pulses at a rate faster than an intrinsic heart rate of a patient in attempt to force the heart to beat in response to the delivered pacing pulses rather than in response to intrinsic cardiac electrical signals. Once the heart is following the pacing pulses, the processing module 210 may control the pulse generator module 204 to reduce the rate of delivered pacing pulses down to a safer level. In CRT, the processing module 210 may control the pulse generator module 204 to deliver pacing pulses in coordination with another device to cause the heart to contract more efficiently. In cases where the pulse generator module 204 is capable of generating defibrillation and/or cardioversion pulses for defibrillation/cardioversion therapy, the processing module 210 may control the pulse generator module 204 to generate such defibrillation and/or cardioversion pulses. In some cases, the processing module 210 may control the pulse generator module 204 to generate electrical stimulation pulses to provide electrical stimulation therapies different than those examples described above.


Aside from controlling the pulse generator module 204 to generate different types of electrical stimulation pulses and in different sequences, in some embodiments, the processing module 210 may also control the pulse generator module 204 to generate the various electrical stimulation pulses with varying pulse parameters. For example, each electrical stimulation pulse may have a pulse width and a pulse amplitude. The processing module 210 may control the pulse generator module 204 to generate the various electrical stimulation pulses with specific pulse widths and pulse amplitudes. For example, the processing module 210 may cause the pulse generator module 204 to adjust the pulse width and/or the pulse amplitude of electrical stimulation pulses if the electrical stimulation pulses are not effectively capturing the heart (e.g. RV or LV capture). Such control of the specific parameters of the various electrical stimulation pulses may help the LCP 200 provide more effective delivery of electrical stimulation therapy.


In some embodiments, the processing module 210 may further control the communication module 202 to send information to other devices. For example, the processing module 210 may control the communication module 202 to generate one or more communication signals for communicating with other devices of a system of devices. For instance, the processing module 210 may control the communication module 202 to generate communication signals in particular pulse sequences, where the specific sequences convey different information. The communication module 202 may also receive communication signals for potential action by the processing module 210.


In further embodiments, the processing module 210 may control switching circuitry by which the communication module 202 and the pulse generator module 204 deliver communication signals and/or electrical stimulation pulses to tissue of the patient. As described above, both the communication module 202 and the pulse generator module 204 may include circuitry for connecting one or more of the electrodes 214, 214′ and/or 214″ to the communication module 202 and/or the pulse generator module 204 so those modules may deliver the communication signals and electrical stimulation pulses to tissue of the patient. The specific combination of one or more electrodes by which the communication module 202 and/or the pulse generator module 204 deliver communication signals and electrical stimulation pulses may influence the reception of communication signals and/or the effectiveness of electrical stimulation pulses. Although it was described that each of the communication module 202 and the pulse generator module 204 may include switching circuitry, in some embodiments, the LCP 200 may have a single switching module connected to the communication module 202, the pulse generator module 204, and the electrodes 214, 214′ and/or 214″. In such embodiments, processing module 210 may control the switching module to connect the modules 202/204 and the electrodes 214/214′/214″ as appropriate. In some cases, the LV electrode 214″ may also be coupled to the switching module and may be used for communication.


In some embodiments, the processing module 210 may include a pre-programmed chip, such as a very-large-scale integration (VLSI) chip or an application specific integrated circuit (ASIC). In such embodiments, the chip may be pre-programmed with control logic in order to control the operation of the LCP 200. By using a pre-programmed chip, the processing module 210 may use less power than other programmable circuits while able to maintain basic functionality, thereby potentially increasing the battery life of the LCP 200. In other instances, the processing module 210 may include a programmable microprocessor or the like. Such a programmable microprocessor may allow a user to adjust the control logic of the LCP 200 after manufacture, thereby allowing for greater flexibility of the LCP 200 than when using a pre-programmed chip. In still other embodiments, the processing module 210 may not be a single component. For example, the processing module 210 may include multiple components positioned at disparate locations within the LCP 200 in order to perform the various described functions. For example, certain functions may be performed in one component of the processing module 210, while other functions are performed in a separate component of the processing module 210.


The processing module 210, in additional embodiments, may include a memory circuit and the processing module 210 may store information on and read information from the memory circuit. In other embodiments, the LCP 200 may include a separate memory circuit (not shown) that is in communication with the processing module 210, such that the processing module 210 may read and write information to and from the separate memory circuit. The memory circuit, whether part of the processing module 210 or separate from the processing module 210, may be volatile memory, non-volatile memory, or a combination of volatile memory and non-volatile memory.


The energy storage module 212 may provide a power source to the LCP 200 for its operations. In some embodiments, the energy storage module 212 may be a non-rechargeable lithium-based battery. In other embodiments, the non-rechargeable battery may be made from other suitable materials. In some embodiments, the energy storage module 212 may be considered to be a rechargeable power supply, such as but not limited to, a rechargeable battery. In still other embodiments, the energy storage module 212 may include other types of energy storage devices such as capacitors or super capacitors. In some cases, as will be discussed, the energy storage module 212 may include a rechargeable primary battery and a non-rechargeable secondary battery. In some cases, the primary battery and the second battery, if present, may both be rechargeable.


To implant the LCP 200 inside a patient's body, an operator (e.g., a physician, clinician, etc.), may fix the LCP 200 to the cardiac tissue of the patient's heart. To facilitate fixation, the LCP 200 may include one or more anchors 216. The one or more anchors 216 may include any number of fixation or anchoring mechanisms. For example, one or more anchors 216 may include one or more pins, staples, threads, screws, helix, tines, and/or the like. In some embodiments, although not shown, one or more anchors 216 may include threads on its external surface that may run along at least a partial length of an anchor member. The threads may provide friction between the cardiac tissue and the anchor to help fix the anchor member within the cardiac tissue. In some cases, the one or more anchors 216 may include an anchor member that has a cork-screw shape that can be screwed into the cardiac tissue. In other embodiments, the anchor 216 may include other structures such as barbs, spikes, or the like to facilitate engagement with the surrounding cardiac tissue.



FIG. 11 is a flow diagram showing an illustrative method 300 for facilitating dual chamber cardiac pacing. In some cases, and as shown at block 302, the method 300 includes advancing an IMD (such as but not limited to the IMD 20, the IMD 50 and/or the IMD 90) to a position proximate a first side of a septum of the heart, the IMD including a housing and two first chamber electrodes disposed relative to the housing, the IMD further including a second chamber electrode and an electrode position adjustment assembly with a coupling for adjusting a position of the second chamber electrode relative to the housing. As seen at block 304, an adjustment tool may be mated to the coupling of the electrode position adjustment assembly. The adjustment tool may be manipulated to move the coupling relative to the housing to adjust the position of the second chamber electrode relative to the housing as seen at block 306. As indicated at block 308, a fixation mechanism may be deployed to secure the IMD relative to the septum.



FIG. 12 is a flow diagram showing an illustrative method 310 for facilitating dual chamber cardiac pacing. In some cases, and as shown at block 302, the method 300 includes advancing an IMD (such as but not limited to the IMD 20, the IMD 50 and/or the IMD 90) to a position proximate a first side of a septum of the heart, the IMD including a housing and two first chamber electrodes disposed relative to the housing, the IMD further including a second chamber electrode and an electrode position adjustment assembly with a coupling for adjusting a position of the second chamber electrode relative to the housing. As seen at block 304, an adjustment tool may be mated to the coupling of the electrode position adjustment assembly. The adjustment tool may be manipulated to move the coupling relative to the housing to adjust the position of the second chamber electrode relative to the housing as seen at block 306.


In some cases, and as indicated at block 312, the method 310 may include testing for capture of the heart. In some cases, the IMD may be at a good location for capture of the heart. In some cases, the initial placement may not yield good capture, and the IMD may be moved to a different position, as indicated at block 314. As shown at block 316, the method 310 may include testing again for capture. In some cases, this may be an iterative process. Once a location with good capture has been found, and as indicated at block 308, a fixation mechanism may be deployed to secure the IMD relative to the septum.



FIG. 13 is a flow diagram showing an illustrative method 318 for facilitating dual chamber cardiac pacing. In some cases, and as shown at block 302, the method 300 includes advancing an IMD (such as but not limited to the IMD 20, the IMD 50 and/or the IMD 90) to a position proximate a first side of a septum of the heart, the IMD including a housing and two first chamber electrodes disposed relative to the housing, the IMD further including a second chamber electrode and an electrode position adjustment assembly with a coupling for adjusting a position of the second chamber electrode relative to the housing. As seen at block 304, an adjustment tool may be mated to the coupling of the electrode position adjustment assembly. The adjustment tool may be manipulated to move the coupling relative to the housing to adjust the position of the second chamber electrode relative to the housing as seen at block 306.


In some cases, and as indicated at block 320, the method 318 may include testing for capture of the heart with the second chamber electrode disposed at a first distance relative to the housing (alternatively, at a first penetration distance into the septum). In some cases, the electrode may be at a good depth for capture of the heart. In some cases, the initial depth may not yield good capture, and the electrode may be moved to a different position relative to the housing (or a different penetration depth), as indicated at block 322. As shown at block 324, the method 318 may include testing again for capture. In some cases, this may be an iterative process. Once a location with good capture has been found, and as indicated at block 308, a fixation mechanism may be deployed to secure the IMD relative to the septum.


In some cases, rather than extending or retracting a single electrode within the septum, the IMD may include a plurality of second chamber electrodes on the outer shaft being extended into the septum. In these cases, rather than moving a single electrode deeper into the septum, or partially withdrawing the single electrode from the septum, each of a series of individually addressable electrodes can be tested for capture.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments.

Claims
  • 1. An implantable medical device (IMD) configured for deployment at a ventricular septum of a patient's heart, the ventricular septum of the patient's heart having a right ventricle (RV) facing side and a left ventricle (LV) facing side, the IMD comprising: a housing having a proximal end and a distal end, the housing configured to fit within the right ventricle (RV) of the patient's heart with the distal end of the housing proximate the RV facing side of the ventricular septum once the IMD is implanted in the patient's heart;a power source disposed within the housing;circuitry disposed within the housing and operatively coupled to the power source;a first RV electrode adjacent the distal end of the housing and positioned to be facing the RV facing side of the ventricular septum once the IMD is implanted, the first RV electrode operatively coupled with the circuitry in the housing;a second RV electrode spaced proximally of the first RV electrode, the second RV electrode operatively coupled with the circuitry in the housing;an LV electrode positioned distally of the first RV electrode and extends at least partially through the ventricular septum once the IMD is implanted, the LV electrode operatively coupled with the circuitry in the housing; andan LV electrode position adjustment assembly for adjusting a distance that the LV electrode is positioned distally of the first RV electrode, wherein the LV electrode position adjustment assembly comprises a coupling secured relative to the housing, wherein the coupling is configured to mate with a separate adjustment tool that can move the coupling relative to the housing to adjust the distance that the LV electrode is positioned distally of the first RV electrode.
  • 2. The IMD of claim 1, wherein the LV electrode position adjustment assembly comprises a fixation helix extending distally from the housing, with the LV electrode positioned on the fixation helix, the fixation helix including a proximal shaft portion extending through a lumen of the housing and terminating in the coupling such that rotating the coupling rotates the fixation helix relative to the housing and causes the fixation helix to thread itself into the ventricular septum.
  • 3. The IMD of claim 1, wherein the LV electrode position adjustment assembly comprises: an inner shaft operatively coupled to the coupling; andan outer shaft threadedly engaged with the inner shaft and configured to not rotate relative to the housing, wherein rotation of the inner shaft via the coupling results in translation of the outer shaft relative to the housing, wherein the LV electrode is secured relative to the outer shaft and translates with the outer shaft.
  • 4. The IMD of claim 3, wherein at least a portion of the outer shaft has a cross-sectional profile that engages a complementary engagement portion of the housing to prevent rotation of the outer shaft relative to the housing.
  • 5. The IMD of claim 4, wherein the cross-sectional profile comprises a non-circular cross-sectional profile and the complementary engagement portion of the housing comprises a distal opening in a lumen that receives at least part of the outer shaft.
  • 6. The IMD of claim 3, wherein the coupling comprises a rotatable tether loop coupled to a proximal end of the inner shaft, such that rotating the rotatable tether loop rotates the inner shaft relative to the outer shaft, thereby causing the outer shaft to translate in response.
  • 7. The IMD of claim 3, further comprising a spring contact disposed within the housing and operably coupled with the circuitry, the spring contact making sliding electrical contact with a portion of the outer shaft that is electrically coupled with the LV electrode.
  • 8. The IMD of claim 1, further comprising one or more fixation tines that are configured to extend into the ventricular septum and curve over to anchor the IMD in place relative to the ventricular septum.
  • 9. The IMD of claim 1, wherein the LV electrode serves as an antenna for communication purposes.
  • 10. The IMD of claim 1, wherein the IMD comprises a dual chamber leadless cardiac pacemaker (LCP), and the LCP senses electrical activity on one side of the ventricular septum and delivers an actionable response on the other side of the ventricular septum.
  • 11. An implantable medical device (IMD) configured for deployment within a heart chamber of a patient's heart, near a septum of the patient's heart, the septum of the patient's heart having a first chamber facing side facing the heart chamber and a second opposing chamber facing side, the IMD comprising: a housing configured to be positioned at least in part in the heart chamber proximate the first chamber facing side of the septum once the IMD is implanted in the patient's heart;a power source disposed within the housing;circuitry disposed within the housing and operatively coupled to the power source;one or more first chamber electrodes fixed relative to the housing and positioned to be proximate the first chamber facing side of the heart chamber once the IMD is implanted, the one or more first chamber electrodes operatively coupled with the circuitry in the housing;a lumen defined by the housing;an outer shaft that extends through the lumen and is translatable relative to the lumen;a second chamber electrode disposed at or near a distal end of the outer shaft, the second chamber electrode operably coupled with the circuitry disposed within the housing; andan inner shaft threadedly engaged with the outer shaft such that the inner shaft may be rotated relative to the outer shaft in order to effect translation of the outer shaft relative to the housing, the outer shaft translatable between a retracted position in which the second chamber electrode is proximate the first chamber facing side of the septum and an extended position in which the second chamber electrode extends at least partially into the septum.
  • 12. The IMD of claim 11, wherein at least a portion of the outer shaft has a cross-sectional profile that engages a complementary engagement portion of the housing to prevent rotation of the outer shaft relative to the housing.
  • 13. The IMD of claim 12, wherein the inner shaft extends proximally through the lumen and terminates in coupling such that rotating the coupling rotates the inner shaft relative to the outer shaft.
  • 14. The IMD of claim 11, further comprising one or more fixation tines that are configured to extend into the septum and curve over to anchor the IMD in place relative to the septum.
  • 15. The IMD of claim 11, further comprising a spring contact disposed within the housing and operably coupled with the circuitry, the spring contact making sliding electrical contact with a portion of the outer shaft that is electrically coupled with the second chamber electrode.
  • 16. The IMD of claim 11, wherein the power source comprises a battery.
  • 17. The IMD of claim 11, wherein the IMD comprises a dual chamber leadless cardiac pacemaker (LCP).
  • 18. A method of facilitating dual chamber pacing of a heart, the method comprising: advancing a leadless cardiac pacemaker (LCP) to a position proximate a first side of a septum of the heart, the LCP including a housing and two first chamber electrodes disposed relative to the housing, the LCP further including a second chamber electrode and an electrode position adjustment assembly with a coupling for adjusting a position of the second chamber electrode relative to the housing;mating an adjustment tool to the coupling of the electrode position adjustment assembly;manipulating the adjustment tool to move the coupling relative to the housing to adjust the position of the second chamber electrode relative to the housing; anddeploying a fixation mechanism to secure the LCP relative to the septum.
  • 19. The method of claim 18, further comprising: testing for capture of the heart prior to deploying the fixation mechanism;moving the LCP to a different position proximate the first side of the septum if capture is not achieved; andtesting for capture again.
  • 20. The method of claim 18, further comprising: testing for capture with the second chamber electrode positioned at a first distance relative to the housing;manipulating the adjustment tool to move the coupling relative to the housing to adjust the distance that the second chamber electrode is positioned a second distance relative to the housing; andtesting for capture again.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/377,204 filed on Aug. 19, 2016, the disclosure of which is incorporated herein by reference.

US Referenced Citations (1155)
Number Name Date Kind
3835864 Rasor et al. Sep 1974 A
3943936 Rasor et al. Mar 1976 A
4142530 Wittkampf Mar 1979 A
4151513 Menken et al. Apr 1979 A
4157720 Greatbatch Jun 1979 A
RE30366 Rasor et al. Aug 1980 E
4243045 Maas Jan 1981 A
4250884 Hartlaub et al. Feb 1981 A
4256115 Bilitch Mar 1981 A
4263919 Levin Apr 1981 A
4310000 Lindemans Jan 1982 A
4312354 Walters Jan 1982 A
4323081 Wiebusch Apr 1982 A
4357946 Dutcher et al. Nov 1982 A
4365639 Goldreyer Dec 1982 A
4440173 Hudziak et al. Apr 1984 A
4476868 Thompson Oct 1984 A
4522208 Buffet Jun 1985 A
4537200 Widrow Aug 1985 A
4556063 Thompson et al. Dec 1985 A
4562841 Brockway et al. Jan 1986 A
4593702 Kepski et al. Jun 1986 A
4593955 Leiber Jun 1986 A
4630611 King Dec 1986 A
4635639 Hakala et al. Jan 1987 A
4674508 DeCote Jun 1987 A
4712554 Garson Dec 1987 A
4729376 DeCote Mar 1988 A
4754753 King Jul 1988 A
4759366 Callaghan Jul 1988 A
4776338 Lekholm et al. Oct 1988 A
4787389 Tarjan Nov 1988 A
4793353 Borkan Dec 1988 A
4819662 Heil et al. Apr 1989 A
4858610 Callaghan et al. Aug 1989 A
4886064 Strandberg Dec 1989 A
4887609 Cole Dec 1989 A
4928688 Mower May 1990 A
4967746 Vandegriff Nov 1990 A
4987897 Funke Jan 1991 A
4989602 Sholder et al. Feb 1991 A
5012806 De Bellis May 1991 A
5036849 Hauck et al. Aug 1991 A
5040534 Mann et al. Aug 1991 A
5058581 Silvian Oct 1991 A
5078134 Heilman et al. Jan 1992 A
5109845 Yuuchi et al. May 1992 A
5113859 Funke May 1992 A
5113869 Nappholz et al. May 1992 A
5117824 Keimel et al. Jun 1992 A
5127401 Grevious et al. Jul 1992 A
5133353 Hauser Jul 1992 A
5144950 Stoop et al. Sep 1992 A
5170784 Ramon et al. Dec 1992 A
5179945 Van Hofwegen et al. Jan 1993 A
5193539 Schulman et al. Mar 1993 A
5193540 Schulman et al. Mar 1993 A
5241961 Henry Sep 1993 A
5243977 Trabucco et al. Sep 1993 A
5259387 DePinto Nov 1993 A
5269326 Verrier Dec 1993 A
5284136 Hauck et al. Feb 1994 A
5300107 Stokes et al. Apr 1994 A
5301677 Hsung Apr 1994 A
5305760 McKown et al. Apr 1994 A
5312439 Loeb May 1994 A
5313953 Yomtov et al. May 1994 A
5314459 Swanson et al. May 1994 A
5318597 Hauck et al. Jun 1994 A
5324316 Schulman et al. Jun 1994 A
5331966 Bennett et al. Jul 1994 A
5334222 Salo et al. Aug 1994 A
5342408 deCoriolis et al. Aug 1994 A
5370667 Alt Dec 1994 A
5372606 Lang et al. Dec 1994 A
5376106 Stahmann et al. Dec 1994 A
5383915 Adams Jan 1995 A
5388578 Yomtov et al. Feb 1995 A
5404877 Nolan et al. Apr 1995 A
5405367 Schulman et al. Apr 1995 A
5411031 Yomtov May 1995 A
5411525 Swanson et al. May 1995 A
5411535 Fujii et al. May 1995 A
5456691 Snell Oct 1995 A
5458622 Alt Oct 1995 A
5466246 Silvian Nov 1995 A
5468254 Hahn et al. Nov 1995 A
5472453 Alt Dec 1995 A
5522866 Fernald Jun 1996 A
5540727 Tockman et al. Jul 1996 A
5545186 Olson et al. Aug 1996 A
5545202 Dahl et al. Aug 1996 A
5571146 Jones et al. Nov 1996 A
5591214 Lu Jan 1997 A
5620466 Haefner et al. Apr 1997 A
5634938 Swanson et al. Jun 1997 A
5649968 Alt et al. Jul 1997 A
5662688 Haefner et al. Sep 1997 A
5674259 Gray Oct 1997 A
5683426 Greenhut et al. Nov 1997 A
5683432 Goedeke et al. Nov 1997 A
5706823 Wodlinger Jan 1998 A
5709215 Perttu et al. Jan 1998 A
5720770 Nappholz et al. Feb 1998 A
5728154 Crossett et al. Mar 1998 A
5741314 Daly et al. Apr 1998 A
5741315 Lee et al. Apr 1998 A
5752976 Duffin et al. May 1998 A
5752977 Grevious et al. May 1998 A
5755736 Gillberg et al. May 1998 A
5759199 Snell et al. Jun 1998 A
5774501 Halpern et al. Jun 1998 A
5792195 Carlson et al. Aug 1998 A
5792202 Rueter Aug 1998 A
5792203 Schroeppel Aug 1998 A
5792205 Alt et al. Aug 1998 A
5792208 Gray Aug 1998 A
5814089 Stokes et al. Sep 1998 A
5827216 Igo et al. Oct 1998 A
5836985 Rostami et al. Nov 1998 A
5836987 Baumann et al. Nov 1998 A
5842977 Lesho et al. Dec 1998 A
5855593 Olson et al. Jan 1999 A
5873894 Vandegriff et al. Feb 1999 A
5891184 Lee et al. Apr 1999 A
5897586 Molina Apr 1999 A
5899876 Flower May 1999 A
5899928 Sholder et al. May 1999 A
5919214 Ciciarelli et al. Jul 1999 A
5935078 Feierbach Aug 1999 A
5941906 Barreras, Sr. et al. Aug 1999 A
5944744 Paul et al. Aug 1999 A
5954757 Gray Sep 1999 A
5978713 Prutchi et al. Nov 1999 A
5991660 Goyal Nov 1999 A
5991661 Park et al. Nov 1999 A
5999848 Gord et al. Dec 1999 A
5999857 Weijand et al. Dec 1999 A
6016445 Baura Jan 2000 A
6026320 Carlson et al. Feb 2000 A
6029085 Olson et al. Feb 2000 A
6041250 DePinto Mar 2000 A
6044298 Salo et al. Mar 2000 A
6044300 Gray Mar 2000 A
6055454 Heemels Apr 2000 A
6073050 Griffith Jun 2000 A
6076016 Feierbach Jun 2000 A
6077236 Cunningham Jun 2000 A
6080187 Alt et al. Jun 2000 A
6083248 Thompson Jul 2000 A
6106551 Crossett et al. Aug 2000 A
6115636 Ryan Sep 2000 A
6128526 Stadler et al. Oct 2000 A
6141581 Olson et al. Oct 2000 A
6141588 Cox et al. Oct 2000 A
6141592 Pauly Oct 2000 A
6144879 Gray Nov 2000 A
6162195 Igo et al. Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6167310 Grevious Dec 2000 A
6201993 Kruse et al. Mar 2001 B1
6208894 Schulman et al. Mar 2001 B1
6211799 Post et al. Apr 2001 B1
6221011 Bardy Apr 2001 B1
6240316 Richmond et al. May 2001 B1
6240317 Villaseca et al. May 2001 B1
6256534 Dahl Jul 2001 B1
6259947 Olson et al. Jul 2001 B1
6266558 Gozani et al. Jul 2001 B1
6266567 Ishikawa et al. Jul 2001 B1
6270457 Bardy Aug 2001 B1
6272377 Sweeney et al. Aug 2001 B1
6273856 Sun et al. Aug 2001 B1
6277072 Bardy Aug 2001 B1
6280380 Bardy Aug 2001 B1
6285907 Kramer et al. Sep 2001 B1
6292698 Duffin et al. Sep 2001 B1
6295473 Rosar Sep 2001 B1
6297943 Carson Oct 2001 B1
6298271 Weijand Oct 2001 B1
6307751 Bodony et al. Oct 2001 B1
6312378 Bardy Nov 2001 B1
6315721 Schulman et al. Nov 2001 B2
6336903 Bardy Jan 2002 B1
6345202 Richmond et al. Feb 2002 B2
6351667 Godie Feb 2002 B1
6351669 Hartley et al. Feb 2002 B1
6353759 Hartley et al. Mar 2002 B1
6358203 Bardy Mar 2002 B2
6361780 Ley et al. Mar 2002 B1
6368284 Bardy Apr 2002 B1
6371922 Baumann et al. Apr 2002 B1
6398728 Bardy Jun 2002 B1
6400982 Sweeney et al. Jun 2002 B2
6400990 Silvian Jun 2002 B1
6408208 Sun Jun 2002 B1
6409674 Brockway et al. Jun 2002 B1
6411848 Kramer et al. Jun 2002 B2
6424865 Ding Jul 2002 B1
6434429 Kraus et al. Aug 2002 B1
6438410 Hsu et al. Aug 2002 B2
6438417 Rockwell et al. Aug 2002 B1
6438421 Stahmann et al. Aug 2002 B1
6440066 Bardy Aug 2002 B1
6441747 Khair et al. Aug 2002 B1
6442426 Kroll Aug 2002 B1
6442432 Lee Aug 2002 B2
6443891 Grevious Sep 2002 B1
6445953 Bulkes et al. Sep 2002 B1
6453200 Koslar Sep 2002 B1
6459929 Hopper et al. Oct 2002 B1
6470215 Kraus et al. Oct 2002 B1
6471645 Warkentin et al. Oct 2002 B1
6480745 Nelson et al. Nov 2002 B2
6487443 Olson et al. Nov 2002 B2
6490487 Kraus et al. Dec 2002 B1
6498951 Larson et al. Dec 2002 B1
6507755 Gozani et al. Jan 2003 B1
6507759 Prutchi et al. Jan 2003 B1
6512940 Brabec et al. Jan 2003 B1
6522915 Ceballos et al. Feb 2003 B1
6526311 Begemann Feb 2003 B2
6539253 Thompson et al. Mar 2003 B2
6542775 Ding et al. Apr 2003 B2
6553258 Stahmann et al. Apr 2003 B2
6561975 Pool et al. May 2003 B1
6564807 Schulman et al. May 2003 B1
6574506 Kramer et al. Jun 2003 B2
6584351 Ekwall Jun 2003 B1
6584352 Combs et al. Jun 2003 B2
6597948 Rockwell et al. Jul 2003 B1
6597951 Kramer et al. Jul 2003 B2
6622046 Fraley et al. Sep 2003 B2
6628985 Sweeney et al. Sep 2003 B2
6647292 Bardy et al. Nov 2003 B1
6666844 Igo et al. Dec 2003 B1
6689117 Sweeney et al. Feb 2004 B2
6690959 Thompson Feb 2004 B2
6694189 Begemann Feb 2004 B2
6704602 Berg et al. Mar 2004 B2
6718212 Parry et al. Apr 2004 B2
6721597 Bardy et al. Apr 2004 B1
6738670 Almendinger et al. May 2004 B1
6746797 Benson et al. Jun 2004 B2
6749566 Russ Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6763269 Cox Jul 2004 B2
6778860 Ostroff et al. Aug 2004 B2
6788971 Sloman et al. Sep 2004 B1
6788974 Bardy et al. Sep 2004 B2
6804558 Haller et al. Oct 2004 B2
6807442 Myklebust et al. Oct 2004 B1
6847844 Sun et al. Jan 2005 B2
6871095 Stahmann et al. Mar 2005 B2
6878112 Linberg et al. Apr 2005 B2
6885889 Chinchoy Apr 2005 B2
6892094 Ousdigian et al. May 2005 B2
6897788 Khair et al. May 2005 B2
6904315 Panken et al. Jun 2005 B2
6922592 Thompson et al. Jul 2005 B2
6931282 Esler Aug 2005 B2
6934585 Schloss et al. Aug 2005 B1
6957107 Rogers et al. Oct 2005 B2
6978176 Lattouf Dec 2005 B2
6985773 Von Arx et al. Jan 2006 B2
6990375 Kloss et al. Jan 2006 B2
7001366 Ballard Feb 2006 B2
7003350 Denker et al. Feb 2006 B2
7006864 Echt et al. Feb 2006 B2
7013178 Reinke et al. Mar 2006 B2
7027871 Burnes et al. Apr 2006 B2
7050849 Echt et al. May 2006 B2
7060031 Webb et al. Jun 2006 B2
7063693 Guenst Jun 2006 B2
7082336 Ransbury et al. Jul 2006 B2
7085606 Flach et al. Aug 2006 B2
7092758 Sun et al. Aug 2006 B2
7110824 Amundson et al. Sep 2006 B2
7120504 Osypka Oct 2006 B2
7130681 Gebhardt et al. Oct 2006 B2
7139613 Reinke et al. Nov 2006 B2
7142912 Wagner et al. Nov 2006 B2
7146225 Guenst et al. Dec 2006 B2
7146226 Lau et al. Dec 2006 B2
7149581 Goedeke Dec 2006 B2
7149588 Lau et al. Dec 2006 B2
7158839 Lau Jan 2007 B2
7162307 Patrias Jan 2007 B2
7164952 Lau et al. Jan 2007 B2
7177700 Cox Feb 2007 B1
7181505 Haller et al. Feb 2007 B2
7184830 Echt et al. Feb 2007 B2
7186214 Ness Mar 2007 B2
7191015 Lamson et al. Mar 2007 B2
7200437 Nabutovsky et al. Apr 2007 B1
7200439 Zdeblick et al. Apr 2007 B2
7206423 Feng et al. Apr 2007 B1
7209785 Kim et al. Apr 2007 B2
7209790 Thompson et al. Apr 2007 B2
7211884 Davis et al. May 2007 B1
7212871 Morgan May 2007 B1
7226440 Gelfand et al. Jun 2007 B2
7228183 Sun et al. Jun 2007 B2
7236821 Cates et al. Jun 2007 B2
7236829 Farazi et al. Jun 2007 B1
7254448 Almendinger et al. Aug 2007 B2
7260436 Kilgore et al. Aug 2007 B2
7270669 Sra Sep 2007 B1
7272448 Morgan et al. Sep 2007 B1
7277755 Falkenberg et al. Oct 2007 B1
7280872 Mosesov et al. Oct 2007 B1
7288096 Chin Oct 2007 B2
7289847 Gill et al. Oct 2007 B1
7289852 Helfinstine et al. Oct 2007 B2
7289853 Campbell et al. Oct 2007 B1
7289855 Nghiem et al. Oct 2007 B2
7302294 Kamath et al. Nov 2007 B2
7305266 Kroll Dec 2007 B1
7310556 Bulkes Dec 2007 B2
7319905 Morgan et al. Jan 2008 B1
7321798 Muhlenberg et al. Jan 2008 B2
7333853 Mazar et al. Feb 2008 B2
7336994 Hettrick et al. Feb 2008 B2
7347819 Lebel et al. Mar 2008 B2
7366572 Heruth et al. Apr 2008 B2
7373207 Lattouf May 2008 B2
7384403 Sherman Jun 2008 B2
7386342 Falkenberg et al. Jun 2008 B1
7392090 Sweeney et al. Jun 2008 B2
7406105 DelMain et al. Jul 2008 B2
7406349 Seeberger et al. Jul 2008 B2
7410497 Hastings et al. Aug 2008 B2
7425200 Brockway et al. Sep 2008 B2
7433739 Salys et al. Oct 2008 B1
7496409 Greenhut et al. Feb 2009 B2
7496410 Heil Feb 2009 B2
7502652 Gaunt et al. Mar 2009 B2
7512448 Malick et al. Mar 2009 B2
7515969 Tockman et al. Apr 2009 B2
7526342 Chin et al. Apr 2009 B2
7529589 Williams et al. May 2009 B2
7532933 Hastings et al. May 2009 B2
7536222 Bardy et al. May 2009 B2
7536224 Ritscher et al. May 2009 B2
7539541 Quiles et al. May 2009 B2
7544197 Kelsch et al. Jun 2009 B2
7558631 Cowan et al. Jul 2009 B2
7565195 Kroll et al. Jul 2009 B1
7584002 Burnes et al. Sep 2009 B2
7590455 Heruth et al. Sep 2009 B2
7606621 Brisken et al. Oct 2009 B2
7610088 Chinchoy Oct 2009 B2
7610092 Cowan et al. Oct 2009 B2
7610099 Almendinger et al. Oct 2009 B2
7610104 Kaplan et al. Oct 2009 B2
7616991 Mann et al. Nov 2009 B2
7617001 Penner et al. Nov 2009 B2
7617007 Williams et al. Nov 2009 B2
7630767 Poore et al. Dec 2009 B1
7634313 Kroll et al. Dec 2009 B1
7637867 Zdeblick Dec 2009 B2
7640060 Zdeblick Dec 2009 B2
7647109 Hastings et al. Jan 2010 B2
7650186 Hastings et al. Jan 2010 B2
7657311 Bardy et al. Feb 2010 B2
7668596 Von Arx et al. Feb 2010 B2
7682316 Anderson et al. Mar 2010 B2
7691047 Ferrari Apr 2010 B2
7702392 Echt et al. Apr 2010 B2
7713194 Zdeblick May 2010 B2
7713195 Zdeblick May 2010 B2
7729783 Michels et al. Jun 2010 B2
7734333 Ghanem et al. Jun 2010 B2
7734343 Ransbury et al. Jun 2010 B2
7738958 Zdeblick et al. Jun 2010 B2
7738964 Von Arx et al. Jun 2010 B2
7742812 Ghanem et al. Jun 2010 B2
7742816 Masoud et al. Jun 2010 B2
7742822 Masoud et al. Jun 2010 B2
7743151 Vallapureddy et al. Jun 2010 B2
7747335 Williams Jun 2010 B2
7751881 Cowan et al. Jul 2010 B2
7758521 Morris et al. Jul 2010 B2
7761150 Ghanem et al. Jul 2010 B2
7761164 Verhoef et al. Jul 2010 B2
7765001 Echt et al. Jul 2010 B2
7769452 Ghanem et al. Aug 2010 B2
7783362 Whitehurst et al. Aug 2010 B2
7792588 Harding Sep 2010 B2
7797059 Bornzin et al. Sep 2010 B1
7801596 Fischell et al. Sep 2010 B2
7809438 Echt et al. Oct 2010 B2
7840281 Kveen et al. Nov 2010 B2
7844331 Li et al. Nov 2010 B2
7844348 Swoyer et al. Nov 2010 B2
7846088 Ness Dec 2010 B2
7848815 Brisken et al. Dec 2010 B2
7848823 Drasler et al. Dec 2010 B2
7860455 Fukumoto et al. Dec 2010 B2
7871433 Lattouf Jan 2011 B2
7877136 Moffitt et al. Jan 2011 B1
7877142 Moaddeb et al. Jan 2011 B2
7881786 Jackson Feb 2011 B2
7881798 Miesel et al. Feb 2011 B2
7881810 Chitre et al. Feb 2011 B1
7890173 Brisken et al. Feb 2011 B2
7890181 Denzene et al. Feb 2011 B2
7890192 Kelsch et al. Feb 2011 B1
7894885 Bartal et al. Feb 2011 B2
7894894 Stadler et al. Feb 2011 B2
7894907 Cowan et al. Feb 2011 B2
7894910 Cowan et al. Feb 2011 B2
7894915 Chitre et al. Feb 2011 B1
7899537 Kroll et al. Mar 2011 B1
7899541 Cowan et al. Mar 2011 B2
7899542 Cowan et al. Mar 2011 B2
7899554 Williams et al. Mar 2011 B2
7901360 Yang et al. Mar 2011 B1
7904170 Harding Mar 2011 B2
7907993 Ghanem et al. Mar 2011 B2
7920928 Yang et al. Apr 2011 B1
7925343 Min et al. Apr 2011 B1
7930022 Zhang et al. Apr 2011 B2
7930040 Kelsch et al. Apr 2011 B1
7937135 Ghanem et al. May 2011 B2
7937148 Jacobson May 2011 B2
7937161 Hastings et al. May 2011 B2
7941214 Kleckner et al. May 2011 B2
7945333 Jacobson May 2011 B2
7946997 Hübinette May 2011 B2
7949404 Hill May 2011 B2
7949405 Feher May 2011 B2
7953486 Daum et al. May 2011 B2
7953493 Fowler et al. May 2011 B2
7962202 Bhunia Jun 2011 B2
7974702 Fain et al. Jul 2011 B1
7979136 Young et al. Jul 2011 B2
7983753 Severin Jul 2011 B2
7991467 Markowitz et al. Aug 2011 B2
7991471 Ghanem et al. Aug 2011 B2
7996087 Cowan et al. Aug 2011 B2
8000791 Sunagawa et al. Aug 2011 B2
8000807 Morris et al. Aug 2011 B2
8001975 DiSilvestro et al. Aug 2011 B2
8002700 Ferek-Petric et al. Aug 2011 B2
8010209 Jacobson Aug 2011 B2
8019419 Panescu et al. Sep 2011 B1
8019434 Quiles et al. Sep 2011 B2
8027727 Freeberg Sep 2011 B2
8027729 Sunagawa et al. Sep 2011 B2
8032219 Neumann et al. Oct 2011 B2
8036743 Savage et al. Oct 2011 B2
8046079 Bange et al. Oct 2011 B2
8046080 Von Arx et al. Oct 2011 B2
8050297 DelMain et al. Nov 2011 B2
8050759 Stegemann et al. Nov 2011 B2
8050774 Kveen et al. Nov 2011 B2
8055345 Li et al. Nov 2011 B2
8055350 Roberts Nov 2011 B2
8060212 Rios et al. Nov 2011 B1
8065018 Haubrich et al. Nov 2011 B2
8073542 Doerr Dec 2011 B2
8078278 Penner Dec 2011 B2
8078283 Cowan et al. Dec 2011 B2
8095123 Gray Jan 2012 B2
8102789 Rosar et al. Jan 2012 B2
8103359 Reddy Jan 2012 B2
8103361 Moser Jan 2012 B2
8112148 Giftakis et al. Feb 2012 B2
8114021 Robertson et al. Feb 2012 B2
8121680 Falkenberg et al. Feb 2012 B2
8123684 Zdeblick Feb 2012 B2
8126545 Flach et al. Feb 2012 B2
8131334 Lu et al. Mar 2012 B2
8140161 Willerton et al. Mar 2012 B2
8150521 Crowley et al. Apr 2012 B2
8160672 Kim et al. Apr 2012 B2
8160702 Mann et al. Apr 2012 B2
8160704 Freeberg Apr 2012 B2
8165694 Carbanaru et al. Apr 2012 B2
8175715 Cox May 2012 B1
8180451 Hickman et al. May 2012 B2
8185213 Kveen et al. May 2012 B2
8187161 Li et al. May 2012 B2
8195293 Limousin et al. Jun 2012 B2
8204595 Pianca et al. Jun 2012 B2
8204605 Hastings et al. Jun 2012 B2
8209014 Doerr Jun 2012 B2
8214043 Matos Jul 2012 B2
8224244 Kim et al. Jul 2012 B2
8229556 Li Jul 2012 B2
8233985 Bulkes et al. Jul 2012 B2
8262578 Bharmi et al. Sep 2012 B1
8265748 Liu et al. Sep 2012 B2
8265757 Mass et al. Sep 2012 B2
8280521 Haubrich et al. Oct 2012 B2
8285387 Utsi et al. Oct 2012 B2
8290598 Boon et al. Oct 2012 B2
8290600 Hastings et al. Oct 2012 B2
8295939 Jacobson Oct 2012 B2
8301254 Mosesov et al. Oct 2012 B2
8315701 Cowan et al. Nov 2012 B2
8315708 Berthelsdorf et al. Nov 2012 B2
8321021 Kisker et al. Nov 2012 B2
8321036 Brockway et al. Nov 2012 B2
8332036 Hastings et al. Dec 2012 B2
8335563 Stessman Dec 2012 B2
8335568 Heruth et al. Dec 2012 B2
8340750 Prakash et al. Dec 2012 B2
8340780 Hastings et al. Dec 2012 B2
8352025 Jacobson Jan 2013 B2
8352028 Wenger Jan 2013 B2
8352038 Mao et al. Jan 2013 B2
8359098 Lund et al. Jan 2013 B2
8364261 Stubbs et al. Jan 2013 B2
8364276 Willis Jan 2013 B2
8369959 Meskens Feb 2013 B2
8369962 Abrahamson Feb 2013 B2
8380320 Spital Feb 2013 B2
8386051 Rys Feb 2013 B2
8391981 Mosesov Mar 2013 B2
8391990 Smith et al. Mar 2013 B2
8406874 Liu et al. Mar 2013 B2
8406879 Shuros et al. Mar 2013 B2
8406886 Gaunt et al. Mar 2013 B2
8412352 Griswold et al. Apr 2013 B2
8417340 Goossen Apr 2013 B2
8417341 Freeberg Apr 2013 B2
8423149 Hennig Apr 2013 B2
8428722 Verhoef et al. Apr 2013 B2
8433402 Ruben et al. Apr 2013 B2
8433409 Johnson et al. Apr 2013 B2
8433420 Bange et al. Apr 2013 B2
8447412 Dal Molin et al. May 2013 B2
8452413 Young et al. May 2013 B2
8457740 Osche Jun 2013 B2
8457742 Jacobson Jun 2013 B2
8457744 Janzig et al. Jun 2013 B2
8457761 Wariar Jun 2013 B2
8478407 Demmer et al. Jul 2013 B2
8478408 Hastings et al. Jul 2013 B2
8478431 Griswold et al. Jul 2013 B2
8494632 Sun et al. Jul 2013 B2
8504156 Bonner et al. Aug 2013 B2
8509910 Sowder et al. Aug 2013 B2
8515559 Roberts et al. Aug 2013 B2
8525340 Eckhardt et al. Sep 2013 B2
8527068 Ostroff Sep 2013 B2
8532790 Griswold Sep 2013 B2
8538526 Stahmann et al. Sep 2013 B2
8541131 Lund et al. Sep 2013 B2
8543205 Ostroff Sep 2013 B2
8547248 Zdeblick et al. Oct 2013 B2
8548605 Ollivier Oct 2013 B2
8554333 Wu et al. Oct 2013 B2
8565882 Matos Oct 2013 B2
8565897 Regnier et al. Oct 2013 B2
8571678 Wang Oct 2013 B2
8577327 Makdissi et al. Nov 2013 B2
8588926 Moore et al. Nov 2013 B2
8612002 Faltys et al. Dec 2013 B2
8615310 Khairkhahan et al. Dec 2013 B2
8626280 Allavatam et al. Jan 2014 B2
8626294 Sheldon et al. Jan 2014 B2
8634908 Cowan Jan 2014 B2
8634912 Bornzin et al. Jan 2014 B2
8634919 Hou et al. Jan 2014 B1
8639335 Peichel et al. Jan 2014 B2
8644934 Hastings et al. Feb 2014 B2
8649859 Smith et al. Feb 2014 B2
8670842 Bornzin et al. Mar 2014 B1
8676319 Knoll Mar 2014 B2
8676335 Katoozi et al. Mar 2014 B2
8700173 Edlund Apr 2014 B2
8700181 Bornzin et al. Apr 2014 B2
8705599 dal Molin et al. Apr 2014 B2
8718766 Wahlberg May 2014 B2
8718773 Willis et al. May 2014 B2
8725260 Shuros et al. May 2014 B2
8738133 Shuros et al. May 2014 B2
8738147 Hastings et al. May 2014 B2
8744555 Allavatam et al. Jun 2014 B2
8744572 Greenhut et al. Jun 2014 B1
8747314 Stahmann et al. Jun 2014 B2
8755884 Demmer et al. Jun 2014 B2
8758365 Bonner et al. Jun 2014 B2
8768483 Schmitt et al. Jul 2014 B2
8774572 Hamamoto Jul 2014 B2
8781605 Bornzin et al. Jul 2014 B2
8788035 Jacobson Jul 2014 B2
8788053 Jacobson Jul 2014 B2
8798740 Samade et al. Aug 2014 B2
8798745 Jacobson Aug 2014 B2
8798762 Fain et al. Aug 2014 B2
8798770 Reddy Aug 2014 B2
8805505 Roberts Aug 2014 B1
8805528 Corndorf Aug 2014 B2
8812109 Blomqvist et al. Aug 2014 B2
8818504 Bodner et al. Aug 2014 B2
8827913 Havel et al. Sep 2014 B2
8831747 Min et al. Sep 2014 B1
8855789 Jacobson Oct 2014 B2
8868186 Kroll Oct 2014 B2
8886339 Faltys et al. Nov 2014 B2
8903473 Rogers et al. Dec 2014 B2
8903500 Smith et al. Dec 2014 B2
8903513 Ollivier Dec 2014 B2
8909336 Navarro-Paredes et al. Dec 2014 B2
8914131 Bornzin et al. Dec 2014 B2
8923795 Makdissi et al. Dec 2014 B2
8923963 Bonner et al. Dec 2014 B2
8938300 Rosero Jan 2015 B2
8942806 Sheldon et al. Jan 2015 B2
8958892 Khairkhahan et al. Feb 2015 B2
8977358 Ewert et al. Mar 2015 B2
8989873 Locsin Mar 2015 B2
8996109 Karst et al. Mar 2015 B2
9002467 Smith et al. Apr 2015 B2
9008776 Cowan et al. Apr 2015 B2
9008777 Dianaty et al. Apr 2015 B2
9014818 Deterre et al. Apr 2015 B2
9017341 Bornzin et al. Apr 2015 B2
9020611 Khairkhahan et al. Apr 2015 B2
9037262 Regnier et al. May 2015 B2
9042984 Demmer et al. May 2015 B2
9072911 Hastings et al. Jul 2015 B2
9072913 Jacobson Jul 2015 B2
9155882 Grubac et al. Oct 2015 B2
9168372 Fain Oct 2015 B2
9168380 Greenhut et al. Oct 2015 B1
9168383 Jacobson et al. Oct 2015 B2
9180285 Moore et al. Nov 2015 B2
9192774 Jacobson Nov 2015 B2
9205225 Khairkhahan et al. Dec 2015 B2
9216285 Boling et al. Dec 2015 B1
9216293 Berthiaume et al. Dec 2015 B2
9216298 Jacobson Dec 2015 B2
9227077 Jacobson Jan 2016 B2
9238145 Wenzel et al. Jan 2016 B2
9242102 Khairkhahan et al. Jan 2016 B2
9242113 Smith et al. Jan 2016 B2
9248300 Rys et al. Feb 2016 B2
9265436 Min et al. Feb 2016 B2
9265962 Dianaty et al. Feb 2016 B2
9272155 Ostroff Mar 2016 B2
9278218 Karst et al. Mar 2016 B2
9278229 Reinke et al. Mar 2016 B1
9283381 Grubac et al. Mar 2016 B2
9283382 Berthiaume et al. Mar 2016 B2
9289612 Sambelashvili et al. Mar 2016 B1
9302115 Molin et al. Apr 2016 B2
9333364 Echt et al. May 2016 B2
9358387 Suwito et al. Jun 2016 B2
9358400 Jacobson Jun 2016 B2
9364675 Deterre et al. Jun 2016 B2
9370663 Moulder Jun 2016 B2
9375580 Bonner et al. Jun 2016 B2
9375581 Baru et al. Jun 2016 B2
9381365 Kibler et al. Jul 2016 B2
9393424 Demmer et al. Jul 2016 B2
9393436 Doerr Jul 2016 B2
9399139 Demmer et al. Jul 2016 B2
9399140 Cho et al. Jul 2016 B2
9409033 Jacobson Aug 2016 B2
9427594 Bornzin et al. Aug 2016 B1
9433368 Stahmann et al. Sep 2016 B2
9433780 Régnier et al. Sep 2016 B2
9457193 Klimovitch et al. Oct 2016 B2
9492668 Sheldon et al. Nov 2016 B2
9492669 Demmer et al. Nov 2016 B2
9492674 Schmidt et al. Nov 2016 B2
9492677 Greenhut et al. Nov 2016 B2
9511233 Sambelashvili Dec 2016 B2
9511236 Varady et al. Dec 2016 B2
9511237 Deterre et al. Dec 2016 B2
9522276 Shen et al. Dec 2016 B2
9522280 Fishler et al. Dec 2016 B2
9526522 Wood et al. Dec 2016 B2
9526891 Eggen et al. Dec 2016 B2
9526909 Stahmann et al. Dec 2016 B2
9533163 Klimovitch et al. Jan 2017 B2
9561382 Persson et al. Feb 2017 B2
9566012 Greenhut et al. Feb 2017 B2
9636511 Carney et al. May 2017 B2
9669223 Auricchio et al. Jun 2017 B2
9687654 Sheldon et al. Jun 2017 B2
9687655 Pertijs et al. Jun 2017 B2
9687659 Von Arx et al. Jun 2017 B2
9694186 Carney et al. Jul 2017 B2
9782594 Stahmann et al. Oct 2017 B2
9782601 Ludwig Oct 2017 B2
9789317 Greenhut et al. Oct 2017 B2
9789319 Sambelashvili Oct 2017 B2
9808617 Ostroff et al. Nov 2017 B2
9808628 Sheldon et al. Nov 2017 B2
9808631 Maile et al. Nov 2017 B2
9808632 Reinke et al. Nov 2017 B2
9808633 Bonner et al. Nov 2017 B2
9808637 Sharma et al. Nov 2017 B2
9855414 Marshall et al. Jan 2018 B2
9855430 Ghosh et al. Jan 2018 B2
9855435 Sahabi et al. Jan 2018 B2
9861815 Tran et al. Jan 2018 B2
20020032470 Linberg Mar 2002 A1
20020035376 Bardy et al. Mar 2002 A1
20020035377 Bardy et al. Mar 2002 A1
20020035378 Bardy et al. Mar 2002 A1
20020035380 Rissmann et al. Mar 2002 A1
20020035381 Bardy et al. Mar 2002 A1
20020042629 Bardy et al. Apr 2002 A1
20020042630 Bardy et al. Apr 2002 A1
20020042634 Bardy et al. Apr 2002 A1
20020049475 Bardy et al. Apr 2002 A1
20020052636 Bardy et al. May 2002 A1
20020068958 Bardy et al. Jun 2002 A1
20020072773 Bardy et al. Jun 2002 A1
20020082665 Haller et al. Jun 2002 A1
20020091414 Bardy et al. Jul 2002 A1
20020095196 Linberg Jul 2002 A1
20020099423 Berg et al. Jul 2002 A1
20020103510 Bardy et al. Aug 2002 A1
20020107545 Rissmann et al. Aug 2002 A1
20020107546 Ostroff et al. Aug 2002 A1
20020107547 Erlinger et al. Aug 2002 A1
20020107548 Bardy et al. Aug 2002 A1
20020107549 Bardy et al. Aug 2002 A1
20020107559 Sanders et al. Aug 2002 A1
20020120299 Ostroff et al. Aug 2002 A1
20020173830 Starkweather et al. Nov 2002 A1
20020193846 Pool et al. Dec 2002 A1
20030009203 Lebel et al. Jan 2003 A1
20030028082 Thompson Feb 2003 A1
20030040779 Engmark et al. Feb 2003 A1
20030041866 Linberg et al. Mar 2003 A1
20030045805 Sheldon et al. Mar 2003 A1
20030088278 Bardy et al. May 2003 A1
20030097153 Bardy et al. May 2003 A1
20030105497 Zhu et al. Jun 2003 A1
20030114908 Flach Jun 2003 A1
20030144701 Mehra et al. Jul 2003 A1
20030187460 Chin et al. Oct 2003 A1
20030187461 Chin Oct 2003 A1
20040024435 Leckrone et al. Feb 2004 A1
20040068302 Rodgers et al. Apr 2004 A1
20040087938 Leckrone et al. May 2004 A1
20040088035 Guenst et al. May 2004 A1
20040102830 Williams May 2004 A1
20040127959 Amundson et al. Jul 2004 A1
20040133242 Chapman et al. Jul 2004 A1
20040147969 Mann et al. Jul 2004 A1
20040147973 Hauser Jul 2004 A1
20040167558 Igo et al. Aug 2004 A1
20040167587 Thompson Aug 2004 A1
20040172071 Bardy et al. Sep 2004 A1
20040172077 Chinchoy Sep 2004 A1
20040172104 Berg et al. Sep 2004 A1
20040176817 Wahlstrand et al. Sep 2004 A1
20040176818 Wahlstrand et al. Sep 2004 A1
20040176830 Fang Sep 2004 A1
20040186529 Bardy et al. Sep 2004 A1
20040204673 Flaherty Oct 2004 A1
20040210292 Bardy et al. Oct 2004 A1
20040210293 Bardy et al. Oct 2004 A1
20040210294 Bardy et al. Oct 2004 A1
20040215308 Bardy et al. Oct 2004 A1
20040220624 Ritscher et al. Nov 2004 A1
20040220626 Wagner Nov 2004 A1
20040220639 Mulligan et al. Nov 2004 A1
20040230283 Prinzen et al. Nov 2004 A1
20040249431 Ransbury et al. Dec 2004 A1
20040260348 Bakken et al. Dec 2004 A1
20040267303 Guenst Dec 2004 A1
20050061320 Lee et al. Mar 2005 A1
20050070962 Echt et al. Mar 2005 A1
20050102003 Grabek et al. May 2005 A1
20050149138 Min et al. Jul 2005 A1
20050165466 Morris et al. Jul 2005 A1
20050182465 Ness Aug 2005 A1
20050203410 Jenkins Sep 2005 A1
20050283208 Von Arx et al. Dec 2005 A1
20050288743 Ahn et al. Dec 2005 A1
20060042830 Maghribi et al. Mar 2006 A1
20060052829 Sun et al. Mar 2006 A1
20060052830 Spinelli et al. Mar 2006 A1
20060064135 Brockway Mar 2006 A1
20060064149 Belacazar et al. Mar 2006 A1
20060085039 Hastings et al. Apr 2006 A1
20060085041 Hastings et al. Apr 2006 A1
20060085042 Hastings et al. Apr 2006 A1
20060095078 Tronnes May 2006 A1
20060106442 Richardson et al. May 2006 A1
20060116746 Chin Jun 2006 A1
20060135999 Bodner et al. Jun 2006 A1
20060136004 Cowan et al. Jun 2006 A1
20060161061 Echt et al. Jul 2006 A1
20060200002 Guenst Sep 2006 A1
20060206151 Lu Sep 2006 A1
20060212079 Routh et al. Sep 2006 A1
20060241701 Markowitz et al. Oct 2006 A1
20060241705 Neumann et al. Oct 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060259088 Pastore et al. Nov 2006 A1
20060265018 Smith et al. Nov 2006 A1
20070004979 Wojciechowicz et al. Jan 2007 A1
20070016098 Kim et al. Jan 2007 A1
20070027508 Cowan Feb 2007 A1
20070078490 Cowan et al. Apr 2007 A1
20070088394 Jacobson Apr 2007 A1
20070088396 Jacobson Apr 2007 A1
20070088397 Jacobson Apr 2007 A1
20070088398 Jacobson Apr 2007 A1
20070088405 Jacobson Apr 2007 A1
20070135882 Drasler et al. Jun 2007 A1
20070135883 Drasler et al. Jun 2007 A1
20070150037 Hastings et al. Jun 2007 A1
20070150038 Hastings et al. Jun 2007 A1
20070156190 Cinbis Jul 2007 A1
20070219525 Gelfand et al. Sep 2007 A1
20070219590 Hastings et al. Sep 2007 A1
20070225545 Ferrari Sep 2007 A1
20070233206 Frikart et al. Oct 2007 A1
20070239244 Morgan et al. Oct 2007 A1
20070255376 Michels et al. Nov 2007 A1
20070276444 Gelbart et al. Nov 2007 A1
20070293900 Sheldon et al. Dec 2007 A1
20070293904 Gelbart et al. Dec 2007 A1
20080004663 Jorgenson Jan 2008 A1
20080021505 Hastings et al. Jan 2008 A1
20080021519 De Geest et al. Jan 2008 A1
20080021532 Kveen et al. Jan 2008 A1
20080065183 Whitehurst et al. Mar 2008 A1
20080065185 Worley Mar 2008 A1
20080071318 Brooke et al. Mar 2008 A1
20080109054 Hastings et al. May 2008 A1
20080119911 Rosero May 2008 A1
20080130670 Kim et al. Jun 2008 A1
20080154139 Shuros et al. Jun 2008 A1
20080154322 Jackson et al. Jun 2008 A1
20080228234 Stancer Sep 2008 A1
20080234771 Chinchoy et al. Sep 2008 A1
20080243217 Wildon Oct 2008 A1
20080269814 Rosero Oct 2008 A1
20080269825 Chinchoy et al. Oct 2008 A1
20080275518 Ghanem et al. Nov 2008 A1
20080275519 Ghanem et al. Nov 2008 A1
20080288039 Reddy Nov 2008 A1
20080294208 Willis et al. Nov 2008 A1
20080294210 Rosero Nov 2008 A1
20080294229 Friedman et al. Nov 2008 A1
20080306359 Zdeblick et al. Dec 2008 A1
20090018599 Hastings et al. Jan 2009 A1
20090024180 Kisker et al. Jan 2009 A1
20090036941 Corbucci Feb 2009 A1
20090048646 Katoozi et al. Feb 2009 A1
20090062895 Stahmann et al. Mar 2009 A1
20090082827 Kveen et al. Mar 2009 A1
20090082828 Ostroff Mar 2009 A1
20090088813 Brockway et al. Apr 2009 A1
20090131907 Chin et al. May 2009 A1
20090135886 Robertson et al. May 2009 A1
20090143835 Pastore et al. Jun 2009 A1
20090171408 Solem Jul 2009 A1
20090171414 Kelly et al. Jul 2009 A1
20090204163 Shuros et al. Aug 2009 A1
20090204170 Hastings et al. Aug 2009 A1
20090210024 M. Aug 2009 A1
20090216292 Pless et al. Aug 2009 A1
20090234407 Hastings et al. Sep 2009 A1
20090234411 Sambelashvili et al. Sep 2009 A1
20090266573 Engmark et al. Oct 2009 A1
20090275998 Burnes et al. Nov 2009 A1
20090275999 Burnes et al. Nov 2009 A1
20090299447 Jensen et al. Dec 2009 A1
20100013668 Kantervik Jan 2010 A1
20100016911 Willis et al. Jan 2010 A1
20100023085 Wu et al. Jan 2010 A1
20100030061 Canfield et al. Feb 2010 A1
20100030327 Chatel Feb 2010 A1
20100042108 Hibino Feb 2010 A1
20100056871 Govari et al. Mar 2010 A1
20100063375 Kassab et al. Mar 2010 A1
20100063562 Cowan et al. Mar 2010 A1
20100069983 Peacock, III et al. Mar 2010 A1
20100094367 Sen Apr 2010 A1
20100114209 Krause et al. May 2010 A1
20100114214 Morelli et al. May 2010 A1
20100125281 Jacobson et al. May 2010 A1
20100168761 Kassab et al. Jul 2010 A1
20100168819 Freeberg Jul 2010 A1
20100198288 Ostroff Aug 2010 A1
20100198304 Wang Aug 2010 A1
20100217367 Belson Aug 2010 A1
20100228308 Cowan et al. Sep 2010 A1
20100234906 Koh Sep 2010 A1
20100234924 Willis Sep 2010 A1
20100241185 Mahapatra et al. Sep 2010 A1
20100249729 Morris et al. Sep 2010 A1
20100286744 Echt et al. Nov 2010 A1
20100298841 Prinzen et al. Nov 2010 A1
20100312309 Harding Dec 2010 A1
20110022113 Zdeblick et al. Jan 2011 A1
20110071586 Jacobson Mar 2011 A1
20110077708 Ostroff Mar 2011 A1
20110112600 Cowan et al. May 2011 A1
20110118588 Komblau et al. May 2011 A1
20110118810 Cowan et al. May 2011 A1
20110137187 Yang et al. Jun 2011 A1
20110144720 Cowan et al. Jun 2011 A1
20110152970 Jollota et al. Jun 2011 A1
20110160558 Rassatt et al. Jun 2011 A1
20110160565 Stubbs et al. Jun 2011 A1
20110160801 Markowitz et al. Jun 2011 A1
20110160806 Lyden et al. Jun 2011 A1
20110166620 Cowan et al. Jul 2011 A1
20110166621 Cowan et al. Jul 2011 A1
20110184491 Kivi Jul 2011 A1
20110190835 Brockway et al. Aug 2011 A1
20110208260 Jacobson Aug 2011 A1
20110218587 Jacobson Sep 2011 A1
20110230734 Fain et al. Sep 2011 A1
20110237967 Moore et al. Sep 2011 A1
20110245890 Brisben et al. Oct 2011 A1
20110251660 Griswold Oct 2011 A1
20110251662 Griswold et al. Oct 2011 A1
20110270099 Ruben et al. Nov 2011 A1
20110270339 Murray, III et al. Nov 2011 A1
20110270340 Pellegrini et al. Nov 2011 A1
20110270341 Ruben et al. Nov 2011 A1
20110276102 Cohen Nov 2011 A1
20110282423 Jacobson Nov 2011 A1
20120004527 Thompson et al. Jan 2012 A1
20120029323 Zhao Feb 2012 A1
20120041508 Rousso et al. Feb 2012 A1
20120059433 Cowan et al. Mar 2012 A1
20120059436 Fontaine et al. Mar 2012 A1
20120065500 Rogers et al. Mar 2012 A1
20120078322 Dal Molin et al. Mar 2012 A1
20120089198 Ostroff Apr 2012 A1
20120093245 Makdissi et al. Apr 2012 A1
20120095521 Hintz Apr 2012 A1
20120095539 Khairkhahan et al. Apr 2012 A1
20120101540 O'Brien et al. Apr 2012 A1
20120101553 Reddy Apr 2012 A1
20120109148 Bonner et al. May 2012 A1
20120109149 Bonner et al. May 2012 A1
20120109236 Jacobson et al. May 2012 A1
20120109259 Bond et al. May 2012 A1
20120116489 Khairkhahan et al. May 2012 A1
20120150251 Giftakis et al. Jun 2012 A1
20120158111 Khairkhahan et al. Jun 2012 A1
20120165827 Khairkhahan et al. Jun 2012 A1
20120172690 Anderson et al. Jul 2012 A1
20120172891 Lee Jul 2012 A1
20120172892 Grubac et al. Jul 2012 A1
20120172942 Berg Jul 2012 A1
20120197350 Roberts et al. Aug 2012 A1
20120197373 Khairkhahan et al. Aug 2012 A1
20120215285 Tahmasian et al. Aug 2012 A1
20120232565 Kveen et al. Sep 2012 A1
20120245665 Friedman et al. Sep 2012 A1
20120277600 Greenhut Nov 2012 A1
20120277606 Ellingson et al. Nov 2012 A1
20120283795 Stancer et al. Nov 2012 A1
20120283807 Deterre et al. Nov 2012 A1
20120289776 Keast et al. Nov 2012 A1
20120289815 Keast et al. Nov 2012 A1
20120290021 Saurkar et al. Nov 2012 A1
20120290025 Keimel Nov 2012 A1
20120296381 Matos Nov 2012 A1
20120303082 Dong et al. Nov 2012 A1
20120316613 Keefe et al. Dec 2012 A1
20130012151 Hankins Jan 2013 A1
20130023975 Locsin Jan 2013 A1
20130035748 Bonner et al. Feb 2013 A1
20130041422 Jacobson Feb 2013 A1
20130053908 Smith et al. Feb 2013 A1
20130053915 Holmstrom et al. Feb 2013 A1
20130053921 Bonner et al. Feb 2013 A1
20130060298 Splett et al. Mar 2013 A1
20130066169 Rys et al. Mar 2013 A1
20130072770 Rao et al. Mar 2013 A1
20130079798 Tran et al. Mar 2013 A1
20130079861 Reinert et al. Mar 2013 A1
20130085350 Schugt et al. Apr 2013 A1
20130085403 Gunderson et al. Apr 2013 A1
20130085550 Polefko et al. Apr 2013 A1
20130096649 Martin et al. Apr 2013 A1
20130103047 Steingisser et al. Apr 2013 A1
20130103109 Jacobson Apr 2013 A1
20130110008 Bourget et al. May 2013 A1
20130110127 Bornzin et al. May 2013 A1
20130110192 Tran et al. May 2013 A1
20130110219 Bornzin et al. May 2013 A1
20130116529 Min et al. May 2013 A1
20130116738 Samade et al. May 2013 A1
20130116740 Bornzin et al. May 2013 A1
20130116741 Bornzin et al. May 2013 A1
20130123872 Bornzin et al. May 2013 A1
20130123875 Varady et al. May 2013 A1
20130131591 Berthiaume et al. May 2013 A1
20130131693 Berthiaume et al. May 2013 A1
20130138006 Bornzin et al. May 2013 A1
20130150695 Biela et al. Jun 2013 A1
20130150911 Perschbacher et al. Jun 2013 A1
20130150912 Perschbacher et al. Jun 2013 A1
20130184776 Shuros et al. Jul 2013 A1
20130192611 Taepke, II et al. Aug 2013 A1
20130196703 Masoud et al. Aug 2013 A1
20130197609 Moore et al. Aug 2013 A1
20130231710 Jacobson Sep 2013 A1
20130238072 Deterre et al. Sep 2013 A1
20130238073 Makdissi et al. Sep 2013 A1
20130253309 Allan et al. Sep 2013 A1
20130253342 Griswold et al. Sep 2013 A1
20130253343 Waldhauser et al. Sep 2013 A1
20130253344 Griswold et al. Sep 2013 A1
20130253345 Griswold et al. Sep 2013 A1
20130253346 Griswold et al. Sep 2013 A1
20130253347 Griswold et al. Sep 2013 A1
20130261497 Pertijs et al. Oct 2013 A1
20130265144 Banna et al. Oct 2013 A1
20130268042 Hastings et al. Oct 2013 A1
20130274828 Willis Oct 2013 A1
20130274847 Ostroff Oct 2013 A1
20130282070 Cowan et al. Oct 2013 A1
20130282073 Cowan et al. Oct 2013 A1
20130296727 Sullivan et al. Nov 2013 A1
20130303872 Taff et al. Nov 2013 A1
20130324825 Ostroff et al. Dec 2013 A1
20130325081 Karst et al. Dec 2013 A1
20130345770 Dianaty et al. Dec 2013 A1
20140012344 Hastings et al. Jan 2014 A1
20140018876 Ostroff Jan 2014 A1
20140018877 Demmer et al. Jan 2014 A1
20140031836 Ollivier Jan 2014 A1
20140039570 Carroll et al. Feb 2014 A1
20140039591 Drasler et al. Feb 2014 A1
20140043146 Makdissi et al. Feb 2014 A1
20140046395 Regnier et al. Feb 2014 A1
20140046420 Moore et al. Feb 2014 A1
20140058240 Mothilal et al. Feb 2014 A1
20140058494 Ostroff et al. Feb 2014 A1
20140074114 Khairkhahan et al. Mar 2014 A1
20140074186 Faltys et al. Mar 2014 A1
20140094891 Pare et al. Apr 2014 A1
20140100624 Ellingson Apr 2014 A1
20140100627 Min Apr 2014 A1
20140107723 Hou et al. Apr 2014 A1
20140121719 Bonner et al. May 2014 A1
20140121720 Bonner et al. May 2014 A1
20140121722 Sheldon et al. May 2014 A1
20140128935 Kumar et al. May 2014 A1
20140135865 Hastings et al. May 2014 A1
20140142648 Smith et al. May 2014 A1
20140148675 Nordstrom et al. May 2014 A1
20140148815 Wenzel et al. May 2014 A1
20140155950 Hastings et al. Jun 2014 A1
20140169162 Romano et al. Jun 2014 A1
20140172060 Bornzin et al. Jun 2014 A1
20140180306 Grubac et al. Jun 2014 A1
20140180366 Edlund Jun 2014 A1
20140207149 Hastings et al. Jul 2014 A1
20140207210 Willis et al. Jul 2014 A1
20140214104 Greenhut et al. Jul 2014 A1
20140222015 Keast et al. Aug 2014 A1
20140222098 Baru et al. Aug 2014 A1
20140222109 Moulder Aug 2014 A1
20140228913 Molin et al. Aug 2014 A1
20140236172 Hastings et al. Aug 2014 A1
20140243848 Auricchio et al. Aug 2014 A1
20140255298 Cole et al. Sep 2014 A1
20140257324 Fain Sep 2014 A1
20140257422 Herken Sep 2014 A1
20140257444 Cole et al. Sep 2014 A1
20140276929 Foster et al. Sep 2014 A1
20140303704 Suwito et al. Oct 2014 A1
20140309706 Jacobson Oct 2014 A1
20140343348 Kaplan et al. Nov 2014 A1
20140371818 Bond et al. Dec 2014 A1
20140379041 Foster Dec 2014 A1
20150025612 Haasl et al. Jan 2015 A1
20150039041 Smith et al. Feb 2015 A1
20150045868 Bonner et al. Feb 2015 A1
20150051609 Schmidt et al. Feb 2015 A1
20150051610 Schmidt et al. Feb 2015 A1
20150051611 Schmidt et al. Feb 2015 A1
20150051612 Schmidt et al. Feb 2015 A1
20150051613 Schmidt et al. Feb 2015 A1
20150051614 Schmidt et al. Feb 2015 A1
20150051615 Schmidt et al. Feb 2015 A1
20150051616 Haasl et al. Feb 2015 A1
20150051682 Schmidt et al. Feb 2015 A1
20150057520 Foster et al. Feb 2015 A1
20150057558 Stahmann et al. Feb 2015 A1
20150057721 Stahmann et al. Feb 2015 A1
20150088155 Stahmann et al. Mar 2015 A1
20150105836 Bonner et al. Apr 2015 A1
20150126854 Keast et al. May 2015 A1
20150157861 Aghassian Jun 2015 A1
20150157866 Demmer et al. Jun 2015 A1
20150173655 Demmer et al. Jun 2015 A1
20150190638 Smith et al. Jul 2015 A1
20150196756 Stahmann et al. Jul 2015 A1
20150196757 Stahmann et al. Jul 2015 A1
20150196758 Stahmann et al. Jul 2015 A1
20150196769 Stahmann et al. Jul 2015 A1
20150217119 Nikolski et al. Aug 2015 A1
20150221898 Chi et al. Aug 2015 A1
20150224315 Stahmann Aug 2015 A1
20150224320 Stahmann Aug 2015 A1
20150230699 Berul et al. Aug 2015 A1
20150238769 Demmer et al. Aug 2015 A1
20150258345 Smith et al. Sep 2015 A1
20150290468 Zhang Oct 2015 A1
20150297905 Greenhut et al. Oct 2015 A1
20150297907 Zhang Oct 2015 A1
20150305637 Greenhut et al. Oct 2015 A1
20150305638 Zhang Oct 2015 A1
20150305639 Greenhut et al. Oct 2015 A1
20150305640 Reinke et al. Oct 2015 A1
20150305641 Stadler et al. Oct 2015 A1
20150305642 Reinke et al. Oct 2015 A1
20150306374 Seifert et al. Oct 2015 A1
20150306375 Marshall et al. Oct 2015 A1
20150306401 Demmer et al. Oct 2015 A1
20150306406 Crutchfield et al. Oct 2015 A1
20150306407 Crutchfield et al. Oct 2015 A1
20150306408 Greenhut et al. Oct 2015 A1
20150321016 O'Brien et al. Nov 2015 A1
20150328459 Chin et al. Nov 2015 A1
20150335884 Khairkhahan et al. Nov 2015 A1
20160015322 Anderson et al. Jan 2016 A1
20160023000 Cho et al. Jan 2016 A1
20160030757 Jacobson Feb 2016 A1
20160033177 Barot et al. Feb 2016 A1
20160067487 Demmer et al. Mar 2016 A1
20160121127 Klimovitch et al. May 2016 A1
20160121128 Fishler et al. May 2016 A1
20160121129 Persson et al. May 2016 A1
20160213919 Suwito et al. Jul 2016 A1
20160213937 Reinke et al. Jul 2016 A1
20160213939 Carney et al. Jul 2016 A1
20160228026 Jackson Aug 2016 A1
20160317825 Jacobson Nov 2016 A1
20160367823 Cowan et al. Dec 2016 A1
20170014629 Ghosh et al. Jan 2017 A1
20170035315 Jackson Feb 2017 A1
20170043173 Sharma et al. Feb 2017 A1
20170043174 Greenhut et al. Feb 2017 A1
20170189681 Anderson Jul 2017 A1
20170281261 Shuros et al. Oct 2017 A1
20170281952 Shuros et al. Oct 2017 A1
20170281953 Min et al. Oct 2017 A1
20170281955 Maile et al. Oct 2017 A1
20170312531 Sawchuk Nov 2017 A1
Foreign Referenced Citations (46)
Number Date Country
2008279789 Oct 2011 AU
2008329620 May 2014 AU
2014203793 Jul 2014 AU
1003904 Jan 1977 CA
202933393 May 2013 CN
0362611 Apr 1990 EP
503823 Sep 1992 EP
1702648 Sep 2006 EP
1904166 Jun 2011 EP
2471452 Jul 2012 EP
2433675 Jan 2013 EP
2441491 Jan 2013 EP
2452721 Nov 2013 EP
2662113 Nov 2013 EP
1948296 Jan 2014 EP
2760541 May 2016 EP
2833966 May 2016 EP
2000051373 Feb 2000 JP
2002502640 Jan 2002 JP
2004512105 Apr 2004 JP
2005508208 Mar 2005 JP
2005245215 Sep 2005 JP
2008540040 Nov 2008 JP
5199867 Feb 2013 JP
9500202 Jan 1995 WO
9636134 Nov 1996 WO
9724981 Jul 1997 WO
9826840 Jun 1998 WO
9939767 Aug 1999 WO
0222206 Mar 2002 WO
0234330 May 2002 WO
02098282 Dec 2002 WO
2005000206 Jan 2005 WO
2005042089 May 2005 WO
2006065394 Jun 2006 WO
2006086435 Aug 2006 WO
2006113659 Oct 2006 WO
2006124833 Nov 2006 WO
2007073435 Jun 2007 WO
2007075974 Jul 2007 WO
2009006531 Jan 2009 WO
2012054102 Apr 2012 WO
2013080038 Jun 2013 WO
2013098644 Jul 2013 WO
2013184787 Dec 2013 WO
2014120769 Aug 2014 WO
Non-Patent Literature Citations (11)
Entry
US 8,886,318 B2, 11/2014, Jacobson et al. (withdrawn)
International Search Report and Written Opinion for Application No. PCT/US2017/047378, 10 pages, dated Dec. 6, 2017.
“Instructions for Use System 1, Leadless Cardiac Pacemaker (LCP) and Delivery Catheter,” Nanostim Leadless Pacemakers, pp. 1-28, 2013.
Hachisuka et al., “Development and Performance Analysis of an Intra-Body Communication Device,” The 12th International Conference on Solid State Sensors, Actuators and Microsystems, vol. 4A1.3, pp. 1722-1725, 2003.
Seyedi et al., “A Survey on Intrabody Communications for Body Area Network Application,” IEEE Transactions on Biomedical Engineering,vol. 60(8): 2067-2079, 2013.
Spickler et al., “Totally Self-Contained Intracardiac Pacemaker,” Journal of Electrocardiology, vol. 3(384): 324-331, 1970.
Wegmüller, “Intra-Body Communication for Biomedical Sensor Networks,” Diss. ETH, No. 17323, 1-173, 2007.
Rad et al., “Left Ventricular Septum Pacing by Transvenous Approach Through the Interventricular Septum,” Maastricht University Medical Center, 18 pages, May 2015.
Henz et al., “Synchronous Ventricular Pacing Without Crossing the Tricuspid Valve or Entering the Coronary Sinus—Preliminary Results,” Mayo Clinic, 7 pages, Jun. 8, 2009.
Asirvatham et al., “Intramyocardial Pacing and Sensing for the Enhancement of Cardiac Stimulation and Sensing Specificity,” Mayo Clinic, 7 pages, Feb. 14, 2007.
Hyde et al., “Beneficial Effect on Cardiac Resynchronization From Left Ventricular Endocardial Pacing is Mediated by Early Access to High Conduction Velocity Tissue,” AHA Journals, 18 pages, Jun. 23, 2015.
Related Publications (1)
Number Date Country
20180050208 A1 Feb 2018 US
Provisional Applications (1)
Number Date Country
62377204 Aug 2016 US